Human Toxoplasma Infection

Toxoplasma Gondii: The Model Apicomplexan - Perspectives and Methods: Second Edition

Volumn , Issue , 2013, Pages 99-159

  McLeod, Rima ^a   Van Tubbergen, Christine ^a   Montoya, José G ^b   Petersen, Eskild ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b STANFORD UNIVERSITY   (United States)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Chorioretinitis; Congenital toxoplasmosis; Diagnosis; Drug therapy; Encephalitis; Immune compromised hosts; Intrauterine infection; Opportunistic infection; Serology; Treatment

Indexed keywords

EID: 84904075459     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-396481-6.00004-0     Document Type: Chapter

References (483)

1. Abgrall S., Rabaud C., Costagliola D. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the high active anti-retroviral therapy era. Clin. Infect. Dis. 2001, 33:1747-1755.
2. Ades A.E. Evaluating the sensitivity and predictive value of tests of recent infection: toxoplasmosis in pregnancy. Epidemiol. Infect. 1991, 107:527-535.
3. Ajzenberg D. High burden of congenital toxoplasmosis in the USA: the strain hypothesis?. Clin. Infect. Dis. 2012, 54(11):1606-1607.
4. Alford C., Stagno S., Reynolds D.W. Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease. Bull. N. Y. Acad. Med. 1974, 50:160-181.
5. Alvarado-Esquivel C., Sethi S., Janitschke K., Hahn H., Liesenfeld O. Comparison of two commercially available avidity tests for Toxoplasma-specific IgG antibodies. Arch. Med. Res. 2002, 33:520-523.
6. Alvarado-Esquivel C., Estrada-Martinez S., Liesenfeld O. Toxoplasma gondii infection in workers occupationally exposed to unwashed raw fruits and vegetables: a case control seroprevalence study. Parasit. Vectors 2011, 4(1):235.
7. Ambroise-Thomas P., Garin J.P., Rigaud A. Improvement of the immunofluorescence technique by the use of counterdyes. Application to Toxoplasma gondii. Presse Med. 1966, 74:2215-2216.
8. Amorim Garcia C.A., de, Orefice F., de Oliveira Lyra C., Gomes A.B., Franca M., Amorim Garcia Filho C.A., de. Socioeconomic conditions as determining factors in the prevalence of systemic and ocular toxoplasmosis in Northeastern Brazil. Ophthalmic Epidemiol. 2004, 11:301-317.
9. Andrade G.M., Vasconcelos-Santos D.V., Carellos E.V., Romanelli R.M., Vitor R.W., Carneiro A.C., Januario J.N. Congenital toxoplasmosis from a chronically infected woman with reactivation of retinochoroiditis during pregnancy. J. Pediatr. (Rio. J.) 2012, 86(1):85-88.
10. Andrews K.T., Haque A., Jones M.K. HDAC inhibitors in parasitic diseases. Immunol. Cell. Biol. 2012, 90(1):66-77.
11. Aptouramani M., Theodoridou M., Syrogiannopoulos G., Mentis A., Papaevangelou V., Gaitana K., Daponte A., Hadjichristodoulou C., the Toxoplasmosis Study Group of the Greece-Cyprus Pediatric Surveillance Unit A dedicated surveillance network for congenital toxoplasmosis in Greece, 2006-2009: assessment of the results. BMC Public Health 2012, 12(1):1019.
12. Araujo F.G., Barnett E.V., Gentry L.O., et al. False-positive anti-Toxoplasma fluorescent-antibody tests in patients with antinuclear antibodies. Appl. Microbiol. 1971, 22:270-275.
13. Araujo F.G., Wong M.M., Theis J., Remington J.S. Experimental Toxoplasm gondii infection in a nonhuman primate. Am. J. Trop. Med. Hyg. 1973, 22(4):465-472.
14. Arslan F., Batirel A., Ramazan M., Ozer S., Mert A. Macrophage activation syndrome triggered by primary disseminated toxoplasmosis. Scand. J. Infect. Dis. 2012, 44(12):1001-1004.
15. Aspöck H., Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand. J. Infect. Dis. 1982, 84(Suppl.):43-45.
16. Aubert D., Foudrinier F., Villena I., Pinon J.M., Biava M.F., Renoult E. PCR diagnosis and follow up of two cases of disseminated toxoplasmosis after kidney grafting. J. Clin. Microbiol. 1996, 34:1347.
17. Aubert G., Maine G.T., Villena I., Hunt J.C., Howard L., Sheu M., Brojanac S., Chovan L.E., Nowlan S.F., Pinon J.M. Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay. J. Clin. Microbiol. 2000, 38:1144-1150.
18. Bahia-Oliverira L.M., Jones J.L., Azevedo-Silva J., et al. Highly endemic, waterborne transmission in north Rio de Janeiro state. Brazil Emerg. Infect. Dis. 2003, 9:55-62.
19. Balsari A., Poli G., Molina V., et al. ELISA for Toxoplasma antibody detection: a comparison with other serodiagnostic tests. J. Clin. Pathol. 1980, 33:640-643.
20. Barbosa B.F., Gomes A.O., Ferro E.A., Napolitano D.R., Mineo J.R., Silva N.M. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models. Vet. Parasitol. 2012, 187(1-2):44-52.
21. Basavaprabhu A., Soundarya M., Deepak M., Satish R. CNS toxoplasmosis presenting with obstructive hydrocephalus in patients of retroviral disease - a case series. Med. J. Malaysia 2012, 67(2):214-216.
22. Bautista G., Ramos A., Forés R., Regidor C., Ruiz E., de Laiglesia A., Navarro B., Bravo J., Portero F., Sanjuan I., Fernández M.N., Cabrera R. Toxoplasmosis in cord blood transplantation recipients. Transpl. Infect. Dis. 2012, 14(5):496-501.
23. Bech-Nielsen S. Toxoplasma gondii associated behavioural changes in mice, rats and humans: evidence from current research. Prev. Vet. Med. 2012, 103(1):78-79.
24. Beghetto E., Buffolano W., Spadoni A., del Pezza M., di Cristina M., Minenkova O., Petersen E., Felici F., Gargano N. Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy. J. Clin. Microbiol. 2003, 41:5414-5418.
25. Beghetto E., Nielsen H.V., Del Porto P., Buffolano W., Guglietta S., Felici F., Petersen E., Gargano N. A combination of antigenic regions of T. gondii microneme proteins induce protective immunity against oral infections with parasite cysts. J. Infect. Dis. 2005, 191:637-645.
26. Beghetto E., Spadoni A., Bruno L., Buffolano W., Gargano N. Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant proteins. J. Clin. Microbiol. 2006, 44(6):2133-2140.
27. Bela S.R., Dutra M.S., Mui E., Montpetit A., Oliveira F.S., Oliveira S.C., Arantes R.M., Antonelli L.R., McLeod R., Gazzinelli R.T. Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii. Infect. Immun. 2012, 80(12):4298-4308.
28. Benenson M.W., Takafuji E.T., Lemon S.M., Greenup R.L., Sulzer A.J. Oocyst-transmitted toxoplasmosis associated with ingestion of contaminated water. N. Engl. J. Med. 1982, 3007:666-669.
29. Benevento J.D., Jager R.D., Noble A.G., et al. Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy. Arch. Ophthalmol. 2008, 126:1152-1156.
30. Benson A., Pifer R., Behrendt C.L., Hooper L.V., Yarovinsky F. Gut commensal bacteria direct a protective immune resposne against Toxoplasma gondii. Cell. Host Microbe. 2012, 6(2):187-196.
31. Berrebi A., Bardou M., Bessieres M., et al. Outcome for children infected with congenital toxoplasmosis in the first trimester and with normal ultrasound findings: A study of 36 cases. Eur. J. Obstet. Gynaecol. Reprod. Bio. 2007, 135:53-57.
32. Binquet C., Wallon M., Quantin C., Kodjikian L., Garweg J., Fleury J., Peyron F., Abrahomawicz M. Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis. Epidemiol. Infect. 2003, 131:1157-1168.
33. Bohne W., Heesemann J., Gross U. Induction of bradyzoite-specific T. gondii antigens in gamma Interferon-treated macrophages. Infect. Immun. 1993, 61:1141-1145.
34. Bories P., Zink E., Mattern J.F., Villard O., Berceanu A., Bilger K., Candolfi E., Herbrecht R., Abou-Bacar A., Lioure B. Febrile pancytopenia as uncommon presentation of disseminated toxoplasmosis after BMT. Bone Marrow Transplant 2012, 47(2):301-303.
35. Botterel F., Ichai P., Feray C., et al. Disseminated toxoplasmosis, resulting from infection of allograft, after orthopedic liver transplantation: usefulness of quantitative PCR. J. Clin. Microbiol. 2002, 40:1648-1650.
36. Boyer K.M., Holfels E., Roizen N., et al. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening. Am. J. Obstet. Gynecol. 2005, 192:564-571.
37. Boyer K., Hill D., Mui E., et al. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin. Infect. Dis. 2011, 53(11):1081.
38. Bowie W.R., King A.S., Werker D.H., Isaac-Renton J.L., Bell A., Eng S.B., Marion S.A. Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet 1997, 350:173-177.
39. Bozzette S., Findelstein D., Spector S., Frame P., Powderly W.G., He W., Phillips L., Craven D., van der Horst C., Feinberg J. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. New England Journal of Medicine 1995, 332:693-699.
40. Bretagne S., Costa J.M., Keuntz M., et al. Late toxoplasmosis evidenced by PCR in marrow transplant recipient. Bone Marrow Transplant 1995, 15:809-811.
41. Brezin A.P., Thulliez P., Couvreur J., et al. Ophthalmic outcome after prenatal and postnatal treatment of congenital toxoplasmosis. Am. J. Ophthalmol. 2003, 138:779-784.
42. Bricker-Hildalgo H., Brenier-Pinchart M.P., Schaal J.P., et al. Value of Toxoplasma gondii detection in one hundred thirty-three placentas for the diagnosis of congenital toxoplasmosis. Pediatr. Infect. Dis. J. 2007, 26:845-846.
43. Brown A.S., Schaefer C.A., Wuesenberry C.P., et al. Maternal expsosure to toxoplasmosis and risk of schizophrenia in adult offspring. Am. J. Psychiatry 2005, 162:767-773.
44. Brownback K.R., Crosser M.S., Simpson S.Q. A 49-year-old man with chest pain and fever after returning from France. Chest 2012, 141(6):1618-1621.
45. Buffolano, W., Beghetto, E., Del Pezzo, M., Spadoni, A., Di Cristina, M., Petersen, E., Gargano, N. (Submitted). Neonatal diagnosis of congenital toxoplasmosis using an enzyme-linked IgM capture assay with a combination of recombinant antigens.
46. Burg J.L., Perelman L., Kasper L.H., Ware P.L., Boothroyd J.C. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J. Immunol. 1988, 141:3584-3591.
47. Burnett A.J., Shortt S.G., Isaac-Renton J., et al. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 1998, 105:1032-1037.
48. Burrowes D., Boyer K., Swisher C.N., et al. Spinal cord lesions in Congenital Toxoplasmosis demonstrated with neuroimaging, including their successful treatment in an adult. J. Neuroparasitology 2012.
49. Busemann C., Ribback S., Zimmermann K., Sailer V., Kiefer T., Schmidt C.A., Schulz K., Steinmetz I., Dombrowski F., Dölken G., Krüger W.H. Toxoplasmosis after allogeneic stem cell transplantation - a single centre experience. Ann. Hematol. 2012, 91(7):1081-1089.
50. Camara D., Bisanz C., Barette C., Van Daele J., Human E., Barnard B., Van der Straeten D., Stove C.P., Lambert W.E., Douce R., Maréchal E., Birkholtz L.M., Cesbron-Delauw M.F., Dumas R., Rébeillé F. Inhibition of p-aminobenzoate and folate syntheses in plants and apicomplexan parasites by natural product rubreserine. J. Biol. Chem. 2012, 287(26):22367-22376.
51. Candolfi E., Bessieres M.H., Mart P., Cimon B., Gandilhon F., Pelloux H., Thulliez P. Determination of a new cut-off value for the diagnosis of congenital toxoplasmosis by detection of specific IgM in an enzyme immunoassay. Eur. J. Clin. Microbiol. Infect. Dis. 1993, 12:396-398.
52. Carme B., Bissuel F., Ajzenberg D., Bouyne R., Aznar C., Demar M., Bichat S., Louvel D., Bourbigot A.M., Peneau C., Neron P., Dardé M.L. Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana. J. Clin. Microbiol. 2002, 2002(40):4037-4044.
53. Carme B., Demar M., Ajzenberg D., Dardé M.L. Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg. Infect. Dis. 2009, 15:656-658.
54. Carneiro A.C., Andrade G.M., Costa J.G., Pinheiro B.V., Vasconcelos-Santos D.V., Ferreira A.D., Su C., Januário J.N., Vitor R.W. Genetic characterization of Toxoplasma gondii revealed highly diverse genotypes from human congenital toxoplasmosis in southeastern Brazil. J. Clin. Microbiol 2013.
55. Capone A. Treatment of neovscularization in infants with retinopathy of prematurity with anti-VEGF: vitreous surgery for retinopathy of prematurity 2006, Paper presented at: Annual Meeting of the American Academy of Ophthalmology, Vegas, NV.
56. Caselli D., Andreoli E., Paolicchi O., Savelli S., Guidi S., Pecile P., Aricò M. Acute encephalopathy in the immune-compromised child: never forget toxoplasmosis. J. Pediatr. Hematol. Oncol. 2012, 34(5):383-386.
57. Cerede O., Dubremetz J.F., Bout D., Lebrun M. The T. gondii protein MIC3 requires pro-peptide cleavage and dimerization to function as adhesion. EMBO J. 2002, 21:2526-2536.
58. Cesbron-Delauw M.F., Tomavo S., Beauchamps P., Fourmaux M.P., Camus D., Capron A., Dubremetz J.F. Similarities between the primary structure of two distinct major surface proteins of Toxoplasma gondii. J. Biol. Chem. 1994, 269:16217-16222.
59. Cesbron-Delauw M.F. The SAG2 antigen of T. gondii and the 31-kDa surface antigen of sarcocystis muris share similar sequence features. Parasitol. Res. 1995, 81:444-445.
60. Chandrasekar P.H., Momin F., the Bone Marrow Transplant Team Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the litreature. Bone Marrow Transpl. 1997, 19:685-689.
61. Chapey E., Wallon M., Debize G., Rabilloud M., Peyron F. Diagnosis of congenital toxoplasmosis by using a whole-blood gamma interferon release assay. J. Clin. Microbiol. 2010, 48(1):41-45.
62. Chew W.K., Segarra I., Ambu S., Mak J.W. Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis. Antimicrob. Agents Chemother. 2012, 56(4):1762-1768.
63. Chiang E., Goldstein D.A., Shapiro M.J., Mets M.B. Branch retinal artery occlusion caused by toxoplasmosis in an adolescent. Case Report Ophthalmol. 2012, 3(3):333-338.
64. Chumpitazi B.F., Boussaid A., Pelloux H., Racinet C., Bost M., Goullier-Fleuret A. Diagnosis of congenital toxoplasmosis by immunoblotting and relationship with other methods. J. Clin. Microbiol. 1995, 33:1479-1485.
65. Cinalli G., Sainte-Rose C., Chumas P., et al. Failure of third ventriculostomy in the treatment of aqueductal stenosis in children. Neurosurg. Focus 1999, 6(4). e3.
66. Collier S.A., Stockman L.J., Hicks L.A., Garrison L.E., Zhou F.J., Beach M.J. Direct healthcare costs of selected diseases primarily or partially transmitted by water. Epidemiol. Infect. 2012, 140(11):2003-2013.
67. Colombo F.A., Vidal J.E., Penalva de Oliveira A.C., Hernandez A.V., Bonasser-Filho F., Nogueira R.S., Focaccia R., Pereira-Chioccola V.L. Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples. J. Clin. Microbiol. 2005, 43:5044-5047.
68. Cong H., Mui E.J., Witola W.H., Sidney J., Alexander J., Sette A., Maewal A., McLeod R. Towards an immunosense vaccine to prevent toxoplasmosis: protetive Toxoplasma gondii epitopes restricted by HLA-A*0201. Vaccine 2011, 29(4):754-762.
69. Cong H., Mui E.J., Witola W.H., Sidney J., Alexander J., Sette A., Maewal A., McLeod R. Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8+T cell epitope based, adjuvanted vaccine protective against. Toxoplasma gondii 2011, 6:12.
70. Cong H., Mui E.J., Witola W.H., Sidney J., Alexander J., Sette A., Maewal A., El Bissati K., Zhou Y., Suzuki Y., Lee D., Woods S., Sommerville C., Henriquez F.L., Roberts C.W., McLeod R. Toxoplasma gondii HLA-B*702-restricted GRA7(20-28) peptide with adjuvants and universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice. Hum. Immunol. 2012, 73(1):1-10.
71. Conley F.K., Jenkins K.A., Remington J.S. Toxoplasma gondii infection of the central nervous system: use of the peroxidase-antiperoxidase method to demonstrate Toxoplasma in formalin-fixed paraffin embedded tissue section. Human Pathology 1981, 12:690-698.
72. Conrad P.A., Miller M.A., Kreuder C., et al. Transmission of Toxoplasma: clues from the study of sea otters as sentinels of Toxoplasma gondii flow into the marine environment. Int. J. Parasitol. 2005, 35(11-12):1155-1168.
73. Cook A.J.C., Gilbert R., Dunn D., Buffolano W., Zuffrey J., Reymondin M., Hohfeld P., Foulon W., Jenum P., Petersen E., Lebech M., Semprini E., Masters J. Sources of Toxoplasma-infection in pregnant women: a European multicentre case-control study. Br. Med. J. 2000, 312:142-147.
74. Cortina-Borja M., Tan H.K., Wallon M., et al. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med. 2010, 7(10):1-11.
75. Couvreur J. Étude de la toxoplasmose congenitale à propo de 20 observation 1955, These. Paris.
76. Couvreur J., Desmonts G. Congenital and maternal toxoplasmosis. A review of 300 cases. Develop. Med. Chld. Neurol. 1962, 4:519-530.
77. Couvreur J., Desmonts G. Late evolution outbreaks of congenital toxoplasmosis. Cah. Coll. Med. Hop. Paris 1964, 115:752-758. French.
78. Couvreur J., Desmonts G., Girre J.Y. Congenital toxoplasmosis in twins: a series of 14 pairs of twins: absence of infection in one twin in two pairs. J. Pediatr. 1976, 89(2):235-240.
79. Couvreur J., Desmonts G., Aron-Rosa D. Le prognostic oculare de la toxoplasmose congenitale: role du traitement. Ann. Pediatr. 1984, 31.
80. Couvreur J., Desmonts G., Thulliez P. Prophylaxis of congenital toxoplasmosis. effects of spiramycin on placental infection. J. Antimicrob. Chemother. 1988, 22:193-200.
81. Couvreur J., Thulliez P., Daffos F., Aufrant C., Bompard Y., Gesquiere A., Desmonts G. In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine. Foetal. Diagn. Ther. 1993, 8(1):45-50.
82. Couvreur J., Thulliez P. Acquired toxoplasmosis with ocular or neurologic involvement. Presse Med. 1996, 25:438-442.
83. Cunningham T. Pancarditis in acute toxoplasmosis. Am. J. Clin. Pathol. 1982, 78:403-405.
84. Daffos F., Forestier F., Capella-Pavlovsky M., et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N. Engl. J. Medicine 1988, 318:271-275.
85. Dai J., Jiang M., Wang Y., Qu L., Gong R., Si J. Evaluation of a recombinant multiepitope peptide for serodiagnosis of Toxoplasma gondii infection. Clin. Vaccine Immunol. 2012, 19(3):338-342.
86. Dai J.F., Jiang M., Qu L.L., Sun L., Wang Y.Y., Gong L.L., Gong R.J., Si J. Toxoplasma gondii: Enzyme-linked immunosorbent assay based on a recombinant multi-epitope peptide for distinguishing recent from past infection in human sera. Exp. Parasitol. 2012, 133(1):95-100.
87. Dannemann B.R., Vaughan W.C., Thulliez P., Remington J.S. Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J. Clin. Microbiol. 1990, 28:1928-1933.
88. Darde M.L., Villena I., Pinon J.M., Beguinot I. Severe toxoplasmosis causd by a Toxoplasma gondii strain with a new isoenzyme type acquired in French Guyana. J. Clin. Microbiol. 1998, 1:324.
89. Darde M.L. Toxoplasma gondii, 'new' genotypes and virulence. Parasite 2008, 15:366-371.
90. Decoster A., Darcy F., Caron A., Vinatier D., Houze De L'Aulnoit D., Vittu G., Niel G., Heyer F., Lecolier B., Delcroix M. Anti-P30 IgA antibodies as prenatal markers of congenital toxoplasma infection. Clin. Exp. Immunol. 1992, 87:310-315.
91. Delair E., Monnet D., Grabar S., Dupouy-Camet J., Yera H., Brezin A.P. Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis. Am. J. Ophthalmol. 2008, 146(6):851-855.
92. Delair E., Latkany P., Noble A.G., et al. Clinical manifestations of ocular toxoplasmosis. Ocul. Immunol. Inflamm. 2011, 19(2):91-102.
93. Demar M., Ajzenberg D., Maubon D., Djossou F., Panchoe D., Punwasi W., Valery N., Peneau C., Daigre J.L., Aznar C., Cottrelle B., Terzan L., Dardé M.L., Carme B. Fatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, clinical, and parasitological aspects. Clin. Infect. Dis. 2007, 45:e88-e95.
94. Demar M., Hommel D., Djossou F., Peneau C., Boukhari R., Louvel D., Bourbigot A.M., Nasser V., Ajzenberg D., Darde M.L., Carme B. Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana. Clin. Microbiol. Infect. 2012, 18:E221-E231.
95. Denes E., Vidal J., Monteil J. Spinal cord toxoplasmosis. Infection 2012.
96. Derouin F., Almadany R., Chau F., Rouveix B., Pocidalo J.J. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis. Antimicrob. Agents Chemother. 1992, 36(5):997-1001.
97. Derouin F. Anti-toxoplasmosis drugs. Curr. Opin. Investig. Drugs 2001, 2(10):1368-1374.
98. Derouin F., Pelloux H., ESCMID Study Group on Clinical Parasitology Prevention of toxoplasmosis in transplant patients. Clin. Microbiol. Infect. 2008, 14(12):1089-1101.
99. Desmonts G., Couvreur J., Ben Rachid M.S. Le toxoplasme, la mère et l'enfant. Arch. Franç. Pédiatr. 1965, 22:1183-1200.
100. Desmonts G., Couvreur J., Alison F., et al. Etude épidémiologique sur la toxoplasmose: de l'Influence de la cuisson des viandes de boucherie sur la fréquence de l'Infection Humaine. Rev. Franc. Etud. Clin. Biol. 1965, 10:952-958.
101. Desmonts G., Couvreur J. Congenital toxoplasmosis: a prospective study of 378 pregnancies. N. Engl. J. Med. 1974, 290:1110-1116.
102. Desmonts G., Couvreur J. Toxoplasmosis in pregnancy and its transmission to the foetus. Bull. N. Y. Acad. Med.: Journal of Urban Health 1974, 50:146-159.
103. Desmonts G., Couvreur J. Congenital toxoplasmosis: a prospective study of the offspring of 542 women who acquired toxoplasmosis during pregnancy. Pathophysiology of Congenital Disease: Perinatal Medicine (6th European Congress, Vienna) 1979, 51-60. Stuttgart Georg Thieme Publishers. O. Thalhammer, A. Pollak, K. Baumgarten (Eds.).
104. Desmonts G., Remington J.S. Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity. J. Clin. Microbiol. 1980, 11:562-568.
105. Desmonts G. Acquired toxoplasmosis in pregnant women. Evaluation of the frequency of transmission of Toxoplasma and of congenital toxoplasmosis. Lyon Medical. 1982, 248:115-123.
106. Desmonts G., Couvreur J. Congenital toxoplasmosis. Prospective study of the outcome of pregnancy in 542 women with toxoplasmosis acquired during pregnancy. Ann. Pediatr. (Paris) 1984, 31:805-809.
107. Doggett J.S., Nilsen A., Forquer I., Wegmann K.W., Jones-Brando L., Yolken R.H., Bordón C., Charman S.A., Katneni K., Schultz T., Burrows J.N., Hinrichs D.J., Meunier B., Carruthers V.B., Riscoe M.K. Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(39):15936-15941.
108. Dorfman R.F., Remington J.S. Value of lymph-node biopsy in the diagnosis of acute toxoplasmosis. N. Engl. J. Med. 1973, 289:878-881.
109. Dubey J.P., Sharma S.P., Juranek D.D., Sulzer A.J., Teutsch S.M. Characterization of Toxoplasma gondii isolates from an outbreak of toxoplasmosis in Atlanta, Georgia. Am. J. Vet. Res. 1981, 42(6):1007-1010.
110. Dubey J.P., Lappin M.R., Thulliez P. Long-term antibody responses of cats fed T. gondii tissue cysts. J. Parasitol. 1995, 81:887-893.
111. Dubey J.P. Advances in the life cycle of Toxoplasma gondii. Int. J. Parasitol. 1998, 28(7):1019-1024.
112. Dubey J.P., Beattie C.P. Toxoplasmosis of animals and man 1998, CRC Press, Boca Raton, FL.
113. Dubey J.P., Ferreira L.R., Martins J., McLeod R. Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortality. Parasitology 2012, 139(1):1-13.
114. Dubey J.P., Hill D.E., Rozeboom D.W., Rajendran C., Choudhary S., Ferreira L.R., Kwok O.C., Su C. High prevalence and genotypes of Toxoplasma gondii isolated from organic pigs in northern USA. Vet. Parasitol. 2012, 188(1-2):14-18.
115. Dubey J.P., Lago E.G., Gennari S.M., Su C., Jones J.L. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology 2012, 139(11):1375-1424.
116. Dumetre A., Le Bras C., Baffet M., Meneceur P., Dubey J.P., Derouin F., Dugeut J.P., Joyeux M., Moulin L. Effects of ozone and ultraviolet radiation treatments on the infectivity of Toxoplasma gondii oocysts. Vet. Parasitol. 2008, 153(3-4):209-213.
117. Dunn D., Wallon M., Peyron F., Petersen E., Peckham C.S., Gilbert R.E. Mother to child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999, 353:1829-1833.
118. Dunn D., Newell M.L., Gilbert R., Mok J., Petersen E., Peckham.C. European Collaborative Study and Research Network on Congenital Toxoplasmosis. Low incidence of congenital toxoplasmosis in children born to women infected with human immunodeficiency virus. Eur. J. Obstet. Gyn. Reprod. Hlth. 1996, 68(1-2):93-96.
119. Dutra M.S., Bela S.R., Peixoto-Rangel A.L., Fakiola M., Cruz A.G., Gazzinelli A., Quites H.F., Bahia-Oliveira L.M., Peixe R.G., Campos W.R., Higino-Rocha A.C., Miller N.E., Blackwell J.M., Antonelli L.R., Gazzinelli R.T. Association of a NOD2 gene polymorphism and T-helper 17 cells with presumed ocular toxoplasmosis. J. Infect. Dis. 2013, 207(1):152-163.
120. Eichenwald H.F. Congenital toxoplasmosis: a study of 150 cases. Am. J. Dis. Chld. 1957, 94:411-412.
121. Eichenwald H.F. A study of congenital toxoplasmosis, with particular emphasis on clinical manifestations, sequelae and therapy. Human toxoplasmosis 1960, 41-49. Munksgaard, Copenhagen. J. Siim (Ed.).
122. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J. Immunol. 1972, 109:129-135.
123. Enzensberger W., Helm E.B., Hopp G., Stille W., Fischer P.A. Toxoplasma encephalitis in patients with AIDS. Dtsch. Med. Wochenschr. 1985, 110:83-87.
124. European Multicentre Study on Congenital Toxoplasmosis Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 2003, 110:112-120.
125. Evengård B., Petterson K., Engman M.-L., Wiklund S., Ivarsson S.A., Tear-Fahnehjelm K., Forsgren M., Gilbert R., Malm G. Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol. Infect. 2001, 127:121-127.
126. Eyles D.E., Coleman N. An evaluation of the curative effects of pyrimethamine and sulfadiazine, alone and in combination, on experimental mouse toxoplasmosis. Antibiot. Chemother. 1955, 5:529-539.
127. Fabiani S., Pinto B., Bruschi F. Toxoplasmosis and neuropsychiatric diseases: can serological studies establish a clear relationship?. Neurol. Sci. 2012.
128. Faucher B., Miermont F., Ranque S., Franck J., Piarroux R. Optimization of Toxoplasma gondii DNA extraction from amniotic fluid using NucliSENS easyMAG and comparison with QIAamp DNA minikit. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31(6):1035-1039.
129. Fayyaz H., Rafi J. TORCH screening in polyhydramnios: an observational study. J. Matern. Foetal Neonatal Med. 2012, 25(7):1069-1072.
130. Feldman H.A. Congenital toxoplasmosis - a study of 103 cases. Am. J. Dis. Child. 1953, 86:487.
131. Ferguson D.J., Graham D.I., Hutchison W.M. Pathological changes in the brains of mice infected with Toxoplasma gondii: a histological, immunocytochemical and ultrastructural study. Int. J. Exp. Pathol. 1991, 72(4):463-474.
132. Ferguson D.J., Bowker C., Jeffery K.J., Chamberlain P., Squier W. Congenital toxoplasmosis: continued parasite proliferation in the foetal brain despite maternal immunological control in other tissues. Clin. Infect. Dis. 2013, 56(2):204-208.
133. Fernàndez-Sabé N., Cervera C., Fariñas M.C., Bodro M., Muñoz P., Gurguí M., Torre-Cisneros J., Martín-Dávila P., Noblejas A., Len O., García-Reyne A., Del Pozo J.L., Carratalà J. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. Clin. Infect. Dis. 2012, 54(3):355-361.
134. Ferrandiz J., Mercier C., Wallon M., Picot S., Cesbron-Delauw M.F., Peyron F. Limited value of assays using detection of immunoglobulin G antibodies to the two recombinant dense granule antigens, GRA1 and GRA6 Nt of Toxoplasma gondii, for distinguishing between acute and chronic infections in pregnant women. Clin. Diagn. Lab. Immunol. 2004, 11:1016-1021.
135. Fischer H.G., Stachelhaus S., Sahm M., Meyer H.M., Reichmann G. GRA7, an excretory 29 kDa T. gondii dense granule antigen released by infected host cells. Mol. Biochem. Parasitol. 1998, 91:251-262.
136. Flament-Durand J., Coers C., Waelbroeck C., van Geertruyden J., Tousaint C. Toxoplasmic encephalitis and myositis during treatment with immunodepressive drugs. Acta. Clin. Belg. 1967, 22:44-54.
137. Flegr J. Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis. J. Exp. Biol. 2013, 216(Pt 1):127-133.
138. Flori P., Tardy L., Patural H., et al. Reliability of immunoglobulin G anti-Toxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women. Clin. Diagn. Lab. Immunol. 2004, 11(4):669-674.
139. Fomovska A., Wood R.D., Mui E., Dubey J.P., Ferreira L.R., Hickman M.R., Lee P.J., Leed S.E., Auschwitz J.M., Welsh W.J., Sommerville C., Woods S., Roberts C.W., McLeod R. Salicylanilide inhibitors of Toxoplasma gondii. J. Med. Chem. 2012, 55(19):8375-8391.
140. Forestier F. Foetal disease, prenatal diagnosis and practical measures. Presse Med. 1991, 1448-1454.
141. Forsgren M., Gille E., Ljungstrom I. Toxoplasma antibodies in pregnant women in Sweden in 1969, 1979 and 1987. Lancet 1991, 337:1413-1414.
142. Foulon W., Naessens A., Derde M.P. Evaluation of the possibilities for preventing congenital toxoplasmosis. Am. J. Perinatol. 1994, 11:57-62.
143. Foulon W., Villena I., Stray-Pedersen B., et al. Treatment of toxoplasmosis during pregnancy: A multicentre study of impact on foetal transmission and children's sequelae at age 1 year. Am. J. Obstet. Gynecol. 1999, 180:410-415.
144. Frenkel J.K., Friedlander S. Toxoplasmosis: pathology of neonatal disease, pathogenesis, diagnosis and treatment 1951, USA Government Printing Office, Washington, Publication n 141. US Public Health Service, p. 107.
145. Frenkel J.K., Hitchings G.H. Relative reversal by vitamins (p-Aminobenzoic, folic and folinic acid) of the effects of sulfadiazine and pyrimethamine on Toxoplasma, mouse and man. Antibiot. Chemother. 1957, 7:630-638.
146. Frenkel J.K., Dubey J.P., Miller N.L. Toxoplasma gondii in cats: fecal stages identified as coccidian oocysts. Science 1970, 167(3919):893-896.
147. Frenkel J.K., Parker B.B. An apparent role of dogs in the transmission of Toxoplasma gondii. The probable importance of xenosmophilia. Ann. N. Y. Acad. Sci. 1996, 791:402-407.
148. Fritz H., Barr B., Packham A., Melli A., Conrad P.A. Methods to produce and safely work with large numbers of Toxoplasma gondii oocysts and bradyzoite cysts. J. Microbiol. Methods 2012, 88(1):47-52.
149. Fritz H.M., Bowyer P.W., Bogyo M., Conrad P.A., Boothroyd J.C. Proteomic analysis of fractionated Toxoplasma oocysts reveals clues to their environmental resistance. PLoS One 2012, 7(1):e29955.
150. Fuentes I., Rodriguez M., Domingo C.J., et al. Urine sample used for congenital toxoplasmosis diagnosis by PCR. J. Clin. Microbiol. 1996, 34(10):2368-2371.
151. Furco A., Carmagnat M., Chevret S., Garin Y.J., Pavie J., De Castro N., Charron D., Derouin F., Rabian C., Molina J.M. Restoration of Toxoplasma gondii-specific immune responses in patients with AIDS staring HAART. AIDS 2008, 22(16):2087-2096.
152. Gallas-Lindemann C., Sotiriadou I., Mahmoodi M.R., Karanis P. Detection of Toxoplasma gondii oocysts in different water resources by Loop Mediated Isothermal Amplification (LAMP). Acta. Trop. 2013, 125(2):231-236.
153. Gallino A., Maggiorini M., Kiowski W., Martin X., Wunderli W., Schneider J., Turina M., Follath F. Toxoplasmosis in heart transplant recipients. Eur. J. Clin. Microbiol. Infect. Dis. 1996, 15:389-393.
154. Garabedian C., Le Goarant J., Delhaes L., Rouland V., Vaast P., Valat A.S., Subtil D., Houfflin-Debarge V. [Periconceptional toxoplasmic seroconversion: about 79 cases]. J. Gynecol. Obstet. Biol. Reprod. (Paris) 2012, 41(6):546-552.
155. Garcia-Règuet N., Lebrun M., Fourmaux M.N., Mercereau-Puijalon O., Mann T., Beckers J.M., Samin B., Van Beeumen J., Bout D., Dubremetz J.F. The microneme protein MIC3 of T. gondii is a secretory adhesion that bInds to both the surface of the host cells and the surface of the parasite. Cell. Microbiol. 2000, 2:353-364.
156. Gard S., Magnusson J.H. A glandular form of toxoplasmosis in connection with pregnancy. Acta. Med. Scand. 1951, 141:59-64.
157. Garin J.P., Brossier N., Sung R.T.M., Moyne T. Effect of pyrimethamine sulfadioxine (Fansidar) on an avirulent cystogenic strain of Toxoplasma gondii (Prugniaud strain) in white mice. Bull. Soc. Pathol. Exot. Filiales 1985, 78:821-824.
158. Garweg J.G., Kodjikian L., Peyron F., Binquet C., Fleury J., Grange J.D., Quantin C., Wallon M. [Congential ocular toxoplasmosis - ocular manifestations and prognosis after early diagnosis of infection] 2005, 222(9):721-727.
159. Gerhold R.W., Jessup D.A. Zoonotic Diseases Associated with Free-Roaming Cats 2012, Zoonoses Public Health.
160. Gilbert R.E., Dunn D.T., Lightman S., Murray P.I., Pavesio C.E., Gormley P.D., Masters J., Parker S.P., Stanford M.R. Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol. Infect. 1999, 123:283-289.
161. Gilbert R.E., Gras L., Wallon M., Peyron F., Ades A.E., Dunn D.T. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France. Int. J. Epidemiol. 2001, 30(6):1303-1308.
162. Gilbert R.E., Freeman K., Lago E.G., Bahia-Oliveira L.M., Tan H.K., Wallon M., Buffolano W., Stanford M.R., Petersen E., European Multicentre Study on Congenital Toxoplasmosis (EMSCOT) Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl. Trop. Dis. 2008, 2:e277.
163. Giordano L.F.C.M., Lasmar E.P., Tavora E.R.F., Lasmar M.F. Toxoplasmosis transmitted via kidney allograft: case report and review. Transplant Proc. 2002, 34:498-499.
164. Glasner P.D., Silveira C., Kruszon-Moran D., Martins M.C., Burnier Júnior M., Silveira S., Camargo M.E., Nussenblatt R.B., Kaslow R.A., Belfort Júnior R. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am. J. Ophthalmol. 1992, 114:136-144.
165. Godwin R. Toxoplasma gondii and elevated suicide risk. Vet. Rec. 2012, 171(9):225.
166. Gollub E.L., Leroy V., Gilbert R., Chêne G., Wallon M. European Toxoprevention Study Group (EUROTOXO): Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2008, 136(2):137-145.
167. Goodwin D., Hrubec T.C., Klein B.G., Strobl J.S., Werre S.R., Han Q., Zajac A.M., Lindsay D.S. Congenital infection of mice with Toxoplasma gondii induces minimal change in behaviour and no change in neurotransmitter concentrations. J. Parasitol. 2012, 98(4):706-712.
168. Gras L., Gilbert R.E., Wallon M., Peyron F., Cortina-Borja M. Duration of the IgM response in women acquiring T. gondii during pregnancy: implications for clinical practices and cross sectional incidence studies. Epidemiol. Infect. 2004, 132:541-548.
169. Gras L., Wallon M., Pollak A., Cortina-Borja M., Evengard B., Hayde M., Petersen E., Ruth Gilbert R., Multicentre The European, Study on Congenital Toxoplasmosis Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta. Paediatrica. 2005, 94:1721-1731.
170. Greenlee J.E., Johnson W.D., Campa J.F., et al. Adult toxoplasmosis presenting as polymyositis and cerebellar ataxia. Ann. Intern. Med. 1975, 82:367-371.
171. Grigg M.E., Ganatra J., Boothroyd J.C., Margolis T.P. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J. Infect. Dis. 2001, 184:633-639.
172. Gross U., Roos T., Heesemann J. Improved serological diagnosis of T. gondii infection by detection of immunoglobulin A (IgA) and IgM antibodies against P30 by using the immunoblot technique. J. Clin. Microbiol. 1992, 30:1436-1441.
173. Gross U., Luder C.G., Hendgen V., Heeg C., Sauer I., Weidner A., Krczal D., Enders G. Comparative immunoglobulin G antibody profiles between mother and child (CGMC test) for early diagnosis of congenital toxoplasmosis. J. Clin. Microbiol. 2000, 38:3619-3622.
174. Grossman P.L., Remington J.S. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo. Am. J. Trop. Med. Hyg. 1979, 28(3):445-455.
175. Grover C.M., Thulliez P., Remington J.S., Boothroyd J.D. Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. Journal of Clinical Microbiology 1990, 28:2297-2301.
176. Guenter W., Bieliński M., Deptuła A., Zalas-Wiecek P., Piskunowicz M., Szwed K., Buciński A., Gospodarek E., Borkowska A. Does Toxoplasma gondii infection affect cognitive function? A case control study. Folia Parasitol. (Praha) 2012, 59(2):93-98.
177. Guerina N.G., Hsu H.W., Meissner H.C., Maguire J.H., Lynfield R., Stechenberg B., Abroms I., Pasternack M.S., Hoff R., Eaton R.B. Neonatal serologic screening and early treatment for congenital T. gondii infection. The New England Regional Toxoplasma Working Group. N. Engl. J. Med. 1994, 330:1858-1863.
178. Guevara-Silva E.A., Ramírez-Crescencio M.A., Soto-Hernández J.L., Cárdenas G. Central nervous system immune reconstitution inflammatory syndrome in AIDS: experience of a Mexican neurological centre. Clin. Neurol. Neurosurg. 2012, 114(7):852-861.
179. Hamdani N., Daban-Huard C., Lajnef M., Richard J.R., Delavest M., Godin O., Guen E.L., Vederine F.E., Lépine J.P., Jamain S., Houenou J., Corvoisier P.L., Aoki M., Moins-Teisserenc H., Charron D., Krishnamoorthy R., Yolken R., Dickerson F., Tamouza R., Leboyer M. Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. J. Affect Disord 2012.
180. Harning D., Spenter H., Metsis A., Vuust J., Petersen E. Recombinant T. gondii SAG1 (P30) expressed in Eschericia coli is recognized by human Toxoplasma-specific IgM and IgG antibodies. Clin. Diag. Lab. Immunol. 1996, 3:355-357.
181. Harbut M.B., Patel B.A., Yeung B.K., McNamara C.W., Bright A.T., Ballard J., Supek F., Golde T.E., Winzeler E.A., Diagana T.T., Greenbaum D.C. Targeting the ERAD pathway via inhibition of signal peptide peptidase for antiparasitic therapeutic design. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(52):21486-21491.
182. Haverkos H.W., Remington J.S., Chan J.C. Assessment of Toxoplasma encephalitis (TE) therapy: a cooperative study. Am. J. Med. 1987, 82:907-914.
183. Hedman K., Lappalainen M., Seppala I., Makela O. Recent primary Toxoplasma infection indicated by a low avidity of specific IgG. J. Infect. Dis. 1989, 159:726-739.
184. Hedman K., Lappalainen M., Söderlund M., Hedman L. Avidity of IgG in serodiagnosis of infectious diseases. Rev. Med. Microbiol. 1993, 4:123-129.
185. Henriquez S.A., Brett R., Alexander J., Pratt J., Roberts C.W. Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation 2009, 16(2):122-133.
186. Hermes G., Ajioka J.W., Kelly K.A., et al. Neurological and behavioural abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J. Neuroinflammation 2008, 5:48.
187. Hill D., Coss C., Dubey J.P., et al. Identification of a sporozoite-specific antigen from Toxoplasma gondii. J. Parasitol. 2011, 97(2):328-337.
188. Hill D.E., Dubey J.P. Toxoplasma gondii prevalence in farm animals in the USA. Int. J. Parasitol 2012.
189. Hogan M.J., Kimura S.J., Lewis A., Zweigart P.A. Early and delayed ocular manifestations of congenital toxoplasmosis. Trans. Am. Ophthalmol. Soc. 1957, 55:275-296.
190. Hohlfeld P., Daffos F., Thulliez P., et al. Foetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J. Pediatr. 1989, 115(5 Pt 1):765-769.
191. Hohlfeld P., Daffos F., Costa J.M., et al. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N. Engl. J. Med. 1994, 695-699.
192. Holec-Gasior L., Ferra B., Drapala D. MIC1-MAG1-SAG1 Chimeric Protein, a Most Effective Antigen for Detection of Human Toxoplasmosis. Clin. Vaccine Immunol. 2012, 19(12):1977-1979.
193. Holec-Ga{ogonek}sior L., Ferra B., Drapała D., Lautenbach D., Kur J. A new MIC1-MAG1 recombinant chimeric antigen can be used instead of the Toxoplasma gondii lysate antigen in serodiagnosis of human toxoplasmosis. Clin. Vaccine Immunol. 2012, 19(1):57-63.
194. Holland G.N., O'Connor G.R., Belfort R., Remington J.S. Toxoplasmosis. Ocular Infection and Immunity 1996, 1183-1223. Mosby Year Book, St Louis. J.S. Pepose, G.N. Holland, K.R. Wilhelmus (Eds.).
195. Holland G.N., Crespi C.M., ten Dam-van Loon N., et al. Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis. Am. J. Ophthalmol. 2008, 145:1007-1013.
196. Holliman R.E., Johnsos J.D., Savva D. Diagnosis of cerebral toxoplasmosis in association with AIDS using the polymerase chain reaction. Scandinavian Journal of Infectious Diseases 1990, 22:243-244.
197. Holliman R.E., Raymond R., Renton N., Johnson J.D. The diagnosis of toxoplasmosis using IgG avidity. Epidemiol. Infect. 1994, 112:399-408.
198. Holmdahl S.C., Holmdahl K. The frequency of congenital toxoplasmosis and some viewpoints on the diagnosis. Acta. Paediatr. 1955, 44:322-329.
199. Holub D., Flegr J., Dragomirecká E., Rodriguez M., Preiss M., Novák T., Cermák J., Horáček J., Kodym P., Libiger J., Höschl C., Motlová L.B. Differences in onset of disease and severity of psychopathology between toxoplasmosis-related and toxoplasmosis-unrelated schizophrenia. Acta. Psychiatr. Scand 2012.
200. Horacek J., Flegr J., Tintera J., Verebova K., Spaniel F., Novak T., Brunovsky M., Bubenikova-Valesova V., Holub D., Palenicek T., Höschl C. Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: voxel-based-morphometry (VBM) study. World J. Biol. Psychiatry 2012, 13(7):501-509.
201. Hotop A., Hlobil H., Gross U. Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy. Clin. Infect. Dis. 2012, 54(11):1545-1552.
202. Howe D.K., Sibley L.D. T. gondii - analysis of different laboratory stocks of the RH strain reveals genetic heterogeneity. Exp. Parasitol. 1994, 78:242-245.
203. Hutchison W.M., Dunachie J.F., Siim J.C., Work K. Coccidian-like nature of Toxoplasma gondii. Br. Med. J. 1970, 1:142-144.
204. Isaac-Renton J., Bowie W.R., King A., et al. Detection of Toxoplasma gondii Oocysts in Drinking Water. Applied and Enviromental Microbiology 1998, 64:2278-2280.
205. Jacobs D., Vercammen M., Saman E. Evaluation of recombinant dense granule antigen 7 (GRA7) of T. gondii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain. Clin. Diag. Lab. Immunol. 1999, 6:24-29.
206. Jamieson S.E., de Roubaix L.A., Cortina-Borja M., et al. Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLoS One 2008, 3(6):e2285.
207. Jamieson S.E., Cordell H., Petersen E., et al. Host genetic and epigenetic factors in toxoplasmosis. Mem. Inst. Oswaldo Cruz 2009, 104(2):162-169.
208. Jamieson S.E., Peixoto-Rangel A.L., Hargrave A.C., et al. Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis. Genes. Immun. 2010, 11(5):374-383.
209. Janku J. Pathogenesa a patologicka anatomie tak nazvaneho vrozenehonalezem parasitu v sitnici. Cas. Lek. Ces. 1923, 62:1021-1027.
210. Jenum P.A., Stray-Pedersen B., Gundersen A.G. Improved diagnosis of primary T. gondii infection in early pregnancy by determination of anti-toxoplasma immunoglobulin G avidity. J. Clin. Microbiol. 1997, 35:1972-1977.
211. Jenum P.A., Stray-Pedersen B. Development of specific immunoglobulins G, M and A following primary T. gondii infection in pregnant women. J. Clin. Microbiol. 1998, 36:2907-2913.
212. Johnson A.M., Roberts H., Tenter A.M. Evaluation of a recombinant antigen ELISA for the diagnosis of acute toxoplasmosis and comparison with traditional ELISAs. J. Med. Microbiol. 1992, 37:404-409.
213. Johnson S.M., Murphy R.C., Geiger J.A., DeRocher A.E., Zhang Z., Ojo K.K., Larson E.T., Perera B.G., Dale E.J., He P., Reid M.C., Fox A.M., Mueller N.R., Merritt E.A., Fan E., Parsons M., Van Voorhis W.C., Maly D.J. Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity. J. Med. Chem. 2012, 55(5):2416-2426.
214. Jones J.L., Kruszon-Moran D., Wilson M., et al. Toxoplasma gondii Infection in the USA: Seroprevalence and Risk Factors. Am. J. Epidemiol. 2001, 154:357-365.
215. Jones J.L., Kruszon-Moran D., Sanders-Lewis K., et al. Toxoplasma gondii infection in the USA, 1999-2004, decline from the prior decade. Am. J. Trop. Med. Hyg. 2007, 77:405-410.
216. Jones J.L., Dargelas V., Roberts J., et al. Risk factors for Toxoplasma gondii infection in the USA. Clin. Infect. Dis. 2009, 49(6):878-884.
217. Jones J.L., Dubey J.P. Foodborne toxoplasmosis. Clin. Infect. Dis. 2012, 55(6):845-851.
218. Jones J.L., Roberts J.M. Toxoplasmosis hospitalizations in the USA, 2008, and trends, 1993-2008. Clin. Infect. Dis. 2012, 54(7):e58-e61.
219. Kaňková S., Sulc J., Křivohlavá R., Kuběna A., Flegr J. Slower postnatal motor development in infants of mothers with latent toxoplasmosis during the first 18 months of life. Early Hum. Dev. 2012, 88(11):879-884.
220. Karanis P., Aldeyarbi H.M., Mirhashemi M.E., Khalil K.M. The impact of the waterborne transmission of Toxoplasma gondii and analysis efforts for water detection: an overview and update. Environ. Sci. Pollut. Res. Int 2012.
221. Kasper L.H., Ware P.L. Identification of stage specific antigens of Toxoplasma gondii. Infect. Immun. 1989, 57:688-692.
222. Kaushik M., Lamberton P.H., Webster J.P. The role of parasites and pathogens in influencing generalised anxiety and predation-related fear in the mammalian central nervous system. Horm. Behav. 2012, 62(3):191-201.
223. Kavitha N., Noordin R., Chan K.L., Sasidharan S. In vitro anti-Toxoplasma gondii activity of root extract/fractions of Eurycoma longifolia Jack. BMC Complement Altern. Med. 2012, 12:91.
224. Khan A., Jordan C., Muccioli C., Vallochi A.L., Rizzo L.V., Belfort R., Vitor R.W., Silveira C., Sibley L.D. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis. Brazil Emerg. Infect. Dis. 2006, 12:942-949.
225. Kimball A.C., Kean B.H., Fuchs F. toxoplasmosis: a prospective study of 4,048 obstetric patients. Am. J. Obstet. Gynaecol. 1971, 111:211-218.
226. Kieffer F., Wallon M., Garcia P., et al. Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr. Infect. Dis. J. 2008, 27-32.
227. Kim J.H., Psevdos G., Gonzalez E., Singh S., Kilayko M.C., Sharp V. All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in New York City in the era of highly active antiretroviral therapy (HAART). Infection 2012.
228. Kimball A., Kean B.H., Fuchs F. Congenital toxoplasmosis: a prospective study of 4,048 obstetric patients. Am. J. Obstet. Gynecol. 1971, 111:211-218.
229. Kodjikian L., Hoigne I., Adam O., Jacquier P., Aebi-Ochsner C., Aebi C., Garweg J.G. Vertical transmission of toxoplasmosis from a chronically infected immunocompetent woman. Pediatr. Infect. Dis. 2004, 23(3):272-274.
230. Kodjikian L., Wallon M., Fleury M., et al. Ocular manifestations in congenital toxoplasmosis. Graefes Arch. Clin. Exp. Ophthalmol. 2006, 244:14-21.
231. Koletzko B., Bauer C.P., Bung P., Cremer M., Flothkötter M., Hellmers C., Kersting M., Krawinkel M., Przyrembel H., Rasenack R., Schäfer T., Vetter K., Wahn U., Weißenborn A., Wöckel A. Gesund ins Leben [Nutrition in pregnancy - Practice recommendations of the Network 'Healthy Start - Young Family Network']. Dtsch Med Wochenschr 2012, 137(25-26):1366-1372.
232. Kong J.T., Grigg M.E., Uyetake L., Parmley S., Boothroyd J.C. Serotyping of Toxoplasma gondii infections in humans using synthetic peptides 2003, 187(9):1484-1495.
233. Koppe J.G., Kloosterman G.J. Congenital toxoplasmosis: long-term follow-up. Padiatr. Padol. 1982, 17:171-179.
234. Koppe J.G., Loewer-Sieger D.H., de Roever-Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1986, 1(8475):254-256.
235. Kortbeek L.M., Hofhuis A., Nijhuis C.D., Havelaar A.H. Congenital toxoplasmosis and DALYs in the Netherlands. Mem. Inst. Oswaldo Cruz 2009, 104(2):370-373.
236. Korhonen M.H., Brunstein J., Haario H., Katnikov A., Rescaldani R., Hedman K. A new method with general diagnostic utility for the calculation of immuglobulin G avidity. Clin. Diag. Lab. Immunol. 1999, 6:725-728.
237. Kotresha D., Poonam D., Muhammad Hafiznur Y., Saadatnia G., Nurulhasanah O., Sabariah O., Tan S.Y., Izzati Zahidah A.K., Rahmah N. Recombinant proteins from new constructs of SAG1 and GRA7 sequences and their usefulness to detect acute toxoplasmosis. Trop. Biomed. 2012, 29(1):129-137.
238. Kovacs J.A. Toxoplasmosis in AIDS: keeping the lid on. Ann. Intern. Med. 1995, 123(3):230-231.
239. Lafferty K.D. Can the common brain parasite, Toxoplasma gondii, influence human culture?. Proc. Biol. Sci. 2006, 273(1602):2749-2755.
240. Lai B.S., Witola W.H., El Bissati K., Zhou Y., Mui E., Fomovska A., McLeod R. Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(35):14182-14187.
241. Lappalainen M., Koskela P., Koskiniemi M., Ämmälä P., Hiilesmaa V., Teramo K., Raivio K.O., Remington J.S., Hedman K. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J. Infect. Dis. 1993, 167:691-697.
242. Lass A., Pietkiewicz H., Szostakowska B., Myjak P. The first detection of Toxoplasma gondii DNA in environmental fruits and vegetables samples. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31(6):1101-1108.
243. Lassoued S., Zabraniecki L., Marin F., et al. Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis. Semin. Arthritis Rheum. 2007, 36:262-263.
244. Lavinsky D., Romano A., Muccioli C., Belfort R. Imaging in ocular toxoplasmosis. Int. Ophthalmol. Clin. 2012, 52(4):131-143.
245. LeFichoux Y., Marty P., Chan H., Doucet J. Détection des IgG anti-toxoplasmiques par I.s.ag.A. A propos de 3,786 sérologies. Bull. Soc. Fr. Parasitol. 1984, 3:13-18.
246. Leal F.E., Cavazzana C.L., de Andrade H.F., Galisteo A.J., de Mendonça J.S., Kallas E.G. Toxoplasma gondii pneumonia in immunocompetent subjects: case report and review. Clin. Infect. Dis. 2007, 15:e62-e66.
247. Lebech M., Andersen O., Christensen N.C., Hertel J., Nielsen H.E., Peitersen B., Rechnitzer C., Larsen S.O., Norgaard-Pedersen B., Petersen E. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 1999, 353:1834-1837.
248. Lecordier L., Fourmaux M.P., Mercier C., Dehecq E., Masy E., Cesbron-Delauw M.F. Enzyme-linked immunosorbent assays using the recombinant dense granule antigens GRA6 and GRA1 of T. gondii for detection of immunoglobulin G antibodies. Clin. Diagn. Lab. Immunol. 2000, 7:607-611.
249. Lecolier B., Pucheu B. Intérêt de l'étude de l'avidité des IgG pour le diagnostic de la toxoplasmose. Pathol. Biol. Paris 1993, 41:155-158.
250. Lee Y., Choi J.Y., Fu H., Harvey C., Ravindran S., Roush W.R., Boothroyd J.C., Khosia C. Chemistry and biology of macrolide antiparasitic agents. J. Med. Chem. 2011, 54(8):2792-2804.
251. Lees M.P., Fuller S.J., McLeod R., et al. P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages. J. Immunol. 2010, 184(12):7040-7046.
252. Lefevre-Pettazzoni M., Bissery A., Wallon M., et al. Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women. Clin. Vaccine Immunol. 2007, 14(3):239-243.
253. Lehmann T., Marcet P.L., Graham D.H., Dahl E.R., Dubey J.P. Globalization and the population structure of Toxoplasma gondii. Proc. Natl. Acad. Sci. USA 2006, 103(30):11423-11428.
254. LePort C., Chene G., Morlat P., et al. Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. J. Infect. Dis. 1996, 173:91-97.
255. Lester D. Toxoplasma gondii and homicide. Psychol. Rep. 2012, 111(1):196-197.
256. Levin M., McLeod R., Young Q., et al. Pneumocystis pneumonia: importance of gallium scan for early diagnosis and description of a new immunoperoxidase technique to demonstrate Pneumocystis carinii. Am. Rev. Respir. Dis. 1983, 128:182-185.
257. Levy R.M., Rosenbloom S., Perrett L.V. Neuroradiologic findings in AIDS: a review of 200 cases. AJNR Am. J. Neurodaiol. 1986, 147:977-983.
258. Levy R.M., Bredesen D.E., Rosenblum M.I. Opportunistic central nervous system pathology in patients with AIDS. Ann. Neurol. 1988, 23:S7-S12.
259. Levy R.M., Mills C.M., Posin J.P., et al. The efficacy and clinical impact of brain imaging in neurologically symptomatic AIDS patients: a prospective CT/MRI study. J. Acquir. Immune. Defic. Syndr. 1990, 3:461-471.
260. Li S., Galvan G., Araujo F.G., Suzuki Y., Remington J.S., Parmley S. Serodiagnosis of recently acquired T. gondii infection. Clin. Diagn. Lab. Immunol. 2000, 7:781-787.
261. Liesenfeld O., Press C., Montoya J.G., Gill R., Isaac-Renton J.L., Hedman K., Remington J.S. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J. Clin. Microbiol. 1997, 1997(35):174-178.
262. Liesenfeld O., Wong S.Y., Remington J.S. Toxoplasmosis in the setting of AIDS. Textbook of AIDS Medicine 1999, 225-259. Williams & Wilkins, Baltimore. J.G. Bartlett, T.C. Merigan, D. Bolognesi (Eds.).
263. Liesenfeld O., Montoya J.G., Kinney S., Press C., Remington J.S. Effect of testing for IgG avidity in the diagnosis of T. gondii infection in pregnant women: experience in a USA reference laboratory. J. Infect. Dis. 2001, 183:1248-1253.
264. Liesenfeld O., Montoya J.G., Kinney S., Press C., Remington J.S. Confirmatory serological testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titres. Am. J. Obstet. Gynecol. 2001, 184:140-145.
265. Lindsay D.S., Collins M.V., Mitchell S.M., et al. Sporulation and survival of Toxoplasmosis gondii oocysts in seawater. J. Eukaryot. Microbiol. 2003, 50:687-688.
266. L'Ollivier C., Wallon M., Faucher B., Piarroux R., Peyron F., Franck J. Comparison of mother and child antibodies that target high-molecular-mass Toxoplasma gondii antigens by immunoblotting improves neonatal diagnosis of congenital toxoplasmosis. Clin. Vaccine Immunol. 2012, 19(8):1326-1328.
267. London N.J., Hovakimyan A., Cubillan L.D., Siverio C.D., Cunningham E.T. Prevalence, clinical characteristics, and causes of vision loss in patients with ocular toxoplasmosis. Eur. J. Ophthalmol. 2011, 21:811-819.
268. Lourenco E.V., Pereira S.R., Faca V.M., Coelho-Castelo A.A.M., Mineo J.R., Roque-Barreira M.C., Greene L.J., Panunto-Castelo A. T. gondii micronemal protein MIC1 is a lactose-binding lectin. Glycobiology 2001, 11:541-547.
269. Luft B.J., Conley F., Remington J.S., et al. Outbreak of central-nervous-system toxoplasmosis in western Europe and North America. Lancet 1983, 1(8328):781-784.
270. Luft B.J., Remington J.S. Acute Toxoplasma infection among family members of patients with acute lymphadenopathic toxoplasmosis. Arch. Intern. Med. 1984, 144:53-56.
271. Luft B.J., Remington J.S. Toxoplasmic encephalitis in AIDS (AIDS commentary). Clin. Infect. Dis. 1992, 15:211-222.
272. Luft B.J., Hafner R., Korzun A.H., et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1993, 329:995-1000.
273. Mack D.G., Johnson J.J., Roberts F., et al. HLA-class II genes modify outcome of Toxoplasma gondii infection. Int. J. Parasitol. 1999, 29(9):1351-1358.
274. Magaldi C., Elkis H., Pattoli D., Coscina A.L. Epidemic of toxoplasmosis at a university in São-José-dos Campos, S.P. Brazil. 1. Clinical and serologic data. Rev. Latinoam Microbiol. Parasitol. (Mex.) 1969, 11(1):5-13.
275. Mahamed D.A., Mills J.H., Egan C.E., Denkers E.Y., Bynoe M.S. CD73-generated adenosine facilitates Toxoplasma gondii differentiation to long-lived tissue cysts in the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(40):16312-16317.
276. Maksimov P., Zerweck J., Maksimov A., Hotop A., Gross U., Spekker K., Däubener W., Werdermann S., Niederstrasser O., Petri E., Mertens M., Ulrich R.G., Conraths F.J., Schares G. Analysis of clonal type-specific antibody reactions in Toxoplasma gondii seropositive humans from Germany by peptide-microarray. PLoS One 2012, 7(3):e34212.
277. Marcolino P.T., Silva D.A.O., Camargo M.E., Mineo J.R. Molecular markers in acute and chronic phases of human Toxoplasmosis: Determination of immunoglobulin G avidity by Western blotting. Clin. Diag. Lab. Immunol. 2000, 7:384-389.
278. Martino R., Bretagne S., Einsele H., et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin. Infect. Dis. 2000, 31:1188-1195.
279. Martino R., Bretagne S., Einsele H., Maertens J., Ullmann A.J., Parody R., Schumacher U., Pautas C., Theunissen K., Schindel C., Munoz C., Margall N. Cordonnier C and the Infectious Disease Working Party of the European Group for Blood and Marrow Transplantation. Early detection of Toxoplasma infection by molecular monitoring of T. gondii in peripheral blood samples after allogenic stem cell transplantation. Clin. Infect. Dis. 2005, 40:67-78.
280. Martins-Duarte E.S., Souza W.D., Vommaro R.C. Toxoplasma gondii: The effect of Fluconazole combined with Sulfadiazine and Pyrimethamine against acute toxoplasmosis in murine model. Exp. Parasitol 2012.
281. Masur H., Jones T.C., Lempert J.A., et al. Outbreak of toxoplasmosis in a family and documentation of acquired retinochoroiditis. Am. J. Med. 1978, 64:396-402.
282. Matsuo Y., Takeishi S., Miyamoto T., et al. Toxoplasmosis encephalitis following severe graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group. Eur. J. Haematol. 2007, 79:317-321.
283. McAuley J., Boyer K.M., Patel D., Mets M., Swisher C., Roizen N., Wolters C., Stein L., Stein M., Schey W. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago Collaborative Treatment Trial. Clinical Infectious Diseases 1994, 18:38-72.
284. McCabe R.E., Brooks R.G., Dorfman R.F., Remington J.S. Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy. Rev. Infect. Dis. 1987, 9:754-774.
285. McLeod R., Berry P.F., Marshall W.H., et al. Toxoplasmosis presenting as brain abscesses. Diagnosis by computerized tomography and cytology of aspirated purulent material. Am. J. Med. 1979, 67(4):711-714.
286. McLeod R., Beem M.O., Estes R.G. Lymphocyte anergy specific to Toxoplasma gondii antigens in a baby with congenital toxoplasmosis. J. Clin. Lab. Immunol. 1985, 17:149-153.
287. McLeod R., Mack D.G., Boyer K., et al. Phenotypes and functions of lymphocytes in congenital toxoplasmosis. J. Lab. Clin. Med. 1990, 116(5):623-635.
288. McLeod R., Mack D., Foss R., et al. Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Antimicrob. Agents Chemother. 1992, 36:1040-1048.
289. McLeod R., Boyer K., Roizen N., Stein L., Swisher C., Holfels E., Hopkins J., Mack D., Karrison T., Patel D., Pfiffner L., Remington J., Withers S., Meyers S., Aitchison V., Mets M., Rabiah P., Meier P. The child with congenital toxoplasmosis. Curr. Clin. Top Infect. Dis. 2000, 20:189-208.
290. McLeod R., Boyer K., Karrison T., Kasza K., Swisher C., Roizen N., Jalbrzikowski J., Remington J., Heydemann P., Noble A.G., Mets M., Holfels E., Withers S., Latkany P., Meier P., Toxoplasmosis Study Group Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin. Infect. Dis. 2006, 42:1383-1394. Epub 2006 Apr 11.
291. McLeod R., Khan A.R., Noble G.A., et al. Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis. Pediatr. Infect. Dis. J. 2006, 25(3):270-272.
292. McLeod R., Kieffer F., Sautter M., Hosten T., Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis?. Mem. Inst. Oswaldo Cruz 2009, 104:320-344.
293. McLeod R., Boyer K.M., Lee D., Mui E., Wroblewski K., Karrison T., Noble A.G., Withers S., Swisher C.N., Heydemann P.T., Sautter M., Babiarz J., Rabiah P., Meier P., Grigg M.E. Toxoplasmosis Study Group. Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009). Clin. Infect. Dis. 2012, 54(11):1595-1605.
294. McLeod, R., Lee, D., Boyer, K. (2013a in press). Toxoplasmosis in the foetus and newborn infant.
295. McLeod, R., Lee, D., Boyer, K. (2013b in press). Diagnosis of congenital toxoplasmosis: a practical procedural atlas.
296. Mele A., Paterson P.J., Prentice H.G., Leoni P., Kibbler C.C. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the litreature. Bone Marrow Transplant 2002, 29:691-698.
297. Meneceur P., Bouldouyre M.A., Aubert D., Villena I., Menotti J., Sauvage V., Garin J.F., Derouin F. In vitro susceptibility of various genotypic strains of Toxoplasma gondii in pyrimethamine, sulfadiazine, and atovaquone. Antimicrob. Agents Chemother. 2008, 52(4):1269-1277.
298. Mennechet F.J., Kasper L.H., Rachinel N., Minns L.A., Luangsay S., Vandewalle A., Buzoni-Gatel D. Intestinal intraepithelial lymphocytes prevent pathogen-driven inflammation and regulate the Smad/T-bet pathway of lamina propria CD4+ T cells. Eur. J. Immunol. 2004, 34(4):1059-1067.
299. Meroni V., Genco F., Tinelli C., et al. Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies. Clin. Vaccine Immunol. 2009, 16(10):1517-1520.
300. Mets M., Holfels E., Boyer K.M., et al. Eye manifestations of congenital toxoplasmosis. Am. J. Ophthalmol. 1996, 122:309-324.
301. Miller M.A., Gardner J.A., Kreuder C., et al. Coastal freshwater runoff is a risk factor for Toxoplasmosis gondii infection of southern sea otters (Enhydra lutris nereis). Int. J. Parasitol. 2002, 32:997-1006.
302. Minot S., Melo M.B., Li F., Lu D., Niedelman W., Levine S.S., Saeij J.P. Admixture and recombination among Toxoplasma gondii lineages explain global genome diversity. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(33):13458-13463.
303. Mitchell C.D., Erlich S.S., Mastrucci M.T., Hutto S.C., Parks W.P., Scott G.B. Congential toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1. Pediatric Infectious Diseases Journal 1990, 9:512-518.
304. Mitra R., Sapolsky R.M., Vyas A. Toxoplasma gondii infection induces dendritic retraction in basolateral amygdala accompanied by reduced corticosterone secretion. Dis. Model Mech 2012.
305. Moncada P.A., Montoya J.G. Toxoplasmosis in the foetus and newborn: an update on prevalence, diagnosis and treatment. Expert Rev. Anti. Infect. Ther. 2012, 10(7):815-828.
306. Montoya J.G., Jordan R., Lingamneni S., et al. Toxoplasmic myocarditis and polymyositis in patients with acute acquired toxoplasmosis diagnosed during life. Clin. Infect. Dis. 1997, 24:676-683.
307. Montoya J.G., Parmley S., Liesenfeld O., Jaffe O., Remington J.S. Use of the poluymerase chain reaction for diagnosis of ocular toxoplasmosis. Ophthalmology 1999, 106:1554-1563.
308. Montoya J.G., Giraldo L.F., Efron B., et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Centre. Clin. Infect. Dis. 2001, 33:629-640.
309. Montoya J.G., Liesenfeld O., Kinney S., Press C., Remington J.S. VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J. Clin. Microbiol. 2002, 40:2504-2508.
310. Montoya J.G. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J. Infect. Dis. 2002 Feb. 15 2002, 185(Suppl. 1):S73-S82.
311. Montoya J.G., Remington J.S. Management of Toxoplasma gondii infection during pregnancy. Clin. Infect. Dis. 2008, 47(4):554-566.
312. Montoya J.G., Boothroyd J.C., Kovacs J.A. Toxoplasma gondii. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Jama: the Journal of the American Medical Association 2010, 274(8):3495-3526.
313. Morelle C., Varlet-Marie E., Brenier-Pinchart M.P., Cassaing S., Pelloux H., Bastien P., Sterkers Y. Comparative assessment of a commercial kit and two laboratory-developed PCR assays for molecular diagnosis of congenital toxoplasmosis. J. Clin. Microbiol. 2012, 50(12):3977-3982.
314. Morin L., Lobry J.R., Peyron F., Wallon M. Seasonal variations in acute toxoplasmosis in pregnant women in the Rhône-Alpes region (France). Clin. Microbiol. Infect. 2012, 18(10):E401-E403.
315. Morris J.G., Greenspan A., Howell K., Gargano L.M., Mitchell J., Jones J.L., Potter M., Isakov A., Woods C., Hughes J.M. Southeastern Centre for Emerging Biologic Threats tabletop exercise: foodborne toxoplasmosis outbreak on college campuses. Biosecur. Bioterror. 2012, 10(1):89-97.
316. Mosti M., Pinto B., Giromella A., Fabiani S., Cristofani R., Panichi M., Bruschi F. A 4-year evaluation of toxoplasmosis seroprevalence in the general population and in women of reproductive age in central Italy. Epidemiol. Infect. 2012, 11:1-4.
317. Mui E.J., Schiehser G.A., Milhous W.K., Hsu H., Roberts C.W., Kirisits M., Muench S., Rice D., Dubey J.P., Fowble J.W., Rathod P.K., Queener S.F., Liu S.R., Jacobus D.P., McLeod R. Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo. PLoS Negl. Trop. Dis. 2008, 2(3):e190.
318. Munro J.B., Silva J.C. Ribonucleotide reductase as a target to control apicomplexan diseases. Curr. Issues Mol. Biol. 2012, 14(1):9-26.
319. Murat J.B., L'Ollivier C., Fricker Hidalgo H., Franck J., Pelloux H., Piarroux R. Evaluation of the new Elecsys Toxo IgG avidity assay for toxoplasmosis and new insights into the interpretation of avidity results. Clin. Vaccine Immunol. 2012, 19(11):1838-1843.
320. Naessens A., Jenum P.A., Pollak A., et al. Diagnosis of congenital toxoplasmosis in the neonatal period: A multicentre evaluation. J. Pediatr. 1999, 135:714-719.
321. Naot Y., Remington J.S. An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii use for diagnosis of acute acquired toxoplasmosis. J. Infect. Dis. 1980, 142:757-766.
322. Naot Y., Desmonts G., Remington J.S. IgM enzyme-linked immunosorbent assay test for the diagnosis of congenital Toxoplasma infection. J. Pediatr. 1981, 98:32-36.
323. Naot Y., Barnett E.V., Remington J.S. Method for avoiding false-positive results occurring in immunoglobulin M enzyme-linked immunosorbent assays due to presence of both rheumatoid factor and antinuclear antibodes. J. Clin. Microbiol. 1981, 14:73-78.
324. Natella V., Cozzolino I., Sosa Fernandez L.V., Vigliar E. Lymph nodes fine needle cytology in the diagnosis of infectious diseases: clinical settings. Infez. Med. 2012, 20(Suppl. 3):12-15.
325. Neto E.C., Rubin R., Schulte J., Giugliani R. Newborn Screening for Congenital Infectious Diseases. Emer. Infect. Dis. 2004, 10:1069-1073.
326. Niebuhr D.W., Millikan A.M., Cowan D.N., et al. Selected infectious agents and risk of schizophrenia among USA military personnel. Am. J. Psychiatry 2008, 165:99-106.
327. Nielsen H.V., Schmidt D.R., Petersen E. Diagnosis of congenital toxoplasmosis by two-dimensional immunoblot differentiation of mother and child IgG-profiles. J. Clin. Microbiol. 2005, 2005(43):711-715.
328. Noble A.G., Latkany P., Kusmierczyk, et al. Chorioretinal lesions in mothers of children with congenital toxoplasmosis in the National Collaborative Chicago-based, Congenital Toxoplasmosis Study. Sci. Med. 2010, 20(1):20-26.
329. Norrby R., Eilard T., Svedhem A., Lycke E. Treatment of toxoplasmosis with trimethoprim-sulphamethoxazole. Scand. J. Infect. Dis. 1975, 7:72-75.
330. O'Connor G.R. Manifestations and management of ocular toxoplasmosis. Bull. NY Acad. Med. 1974, 50:192-210.
331. Odberg-Ferragut C., Soete M., Engels A., Samyn B., Loyens A., van Beeumen J., Camus D., Dubremetz J.F. Molecular cloning of the T. gondii SAG4 gene encoding an 18 kDa bradyzoite specific surface protein. Mol. Biochem. Parasitol. 1996, 82:237-244.
332. Okusaga O., Postolache T.T. Toxoplasma gondii, the immune system, and suicidal behaviour. The Neurological Basis of Suicide 2012, CRC Press, Boca Raton (FL), Chapter 19. Frontiers in Neuroscience. Y. Dwivdei (Ed.).
333. Olariu T., Remington S., McLeod R., Alam A., Montoya J. Severe Congenital Toxoplasmosis in the United State: Clinical and Serologic Findings in Untreated Infants. Pediatr. Infect. Dis. J. 2011, 30(12):1056-1061.
334. Oréfice, J.L., Costa, R.A., Scott, I.U., Calucci, D., Oréfice, F.; on behalf of the Grupo Mineiro de Pesquisa em Doenças Oculares Inflamatórias (MINAS). (2012). Spectral optical coherence tomography findings in patients with ocular toxoplasmosis and active satellite lesions (MINAS Report 1). Acta Ophthalmol.
335. Orr K.E., Gould F.K., Short G., Dark J.H., Hilton C.J., Corris P.A., Freeman R. Outcome of T. gondii mismatches in heart transplant recipients over a period of 8 years. J. Infect. 1994, 29:249-253.
336. Osthoff M., Chew E., Bajel A., Kelsey G., Panek-Hudson Y., Mason K., Szer J., Ritchie D., Slavin M. Disseminated toxoplasmosis after allogeneic stem cell transplantation in a seronegative recipient. Transpl. Infect. Dis 2012.
337. Palma S., Reyes H., Guzman L., et al. Dermatomyositis and toxoplasmosis. Rev. Med. Chil. 1984, 111:164-167.
338. Papoz L., Simondon F., Saurin W., Sarmini H. A simple model relevant to toxoplasmosis applied to epidemiologic results in France. Am. J. Epidemiol. 1986, 154-161.
339. Parmley S.F., Goebel F.D., Remington J.S. Detection of Toxoplasma gondii in cerebrospinal fluid from AIDS patients by polymerase chain reaction. J. Clin. Microbiol. 1992, 30:3000-3002.
340. Parmley S.F., Yang S.M., Harth G., Sibley L.D., Sucharczuk A., Remington J.S. Molecular characterization of a 65-kDa T. gondii antigen expressed abundantly in the matrix of tissue cysts. Mol. Biochem. Parasitol. 1994, 66:283-296.
341. Paspalaki P.K., Mihailidou E.P., Bitsori M., et al. Polymyositis and myocarditis associated with acquired toxoplasmosis in an immunocompetent girl. BMC Musculoskelet Disord. 2001, 2:8.
342. Patel D.V., Holfels E.M., Vogel N.P., et al. Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis. Radiology 1996, 199(2):433-440. 1996.
343. Paul M., Petersen E., Pawlowski Z.S., Szczapa J. Neonatal screening for congenital toxoplasmosis in the Poznan region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr. Infect. Dis. J. 2000, 19:30-36.
344. Pearce B.D., Kruszon-Moran D., Jones J.L. The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey. Biol. Psychiatry 2012, 72(4):290-295.
345. Pedersen M.G., Mortensen P.B., Norgaard-Pedersen B., Postolache T.T. Toxoplasma gondii infection and self-directed violence in mothers. Arch. Gen. Psychiatry 2012, 69(11):1123-1130.
346. Peixoto L., Chen F., Harb O.S., Davis P.H., Beiting D.P., Brownback C.S., Ouloguem D., Roos D.S. Integrative genomic approaches highlight a family of parasite-specific kinases that regulate host responses. Cell. Host Microbe 2010, 8(2):208-218.
347. Pelloux H., Brun E., Vernet G., Marcillat S., Jolivet M., Guergour D., Fricker-Hidalgo H., Goullier-Fleuret A., Ambroise-Thomas P. Determination of anti-T. gondii immunoglobulin G avidity: Adaption to the Vidas system (bioMérieux). Diag. Microbiol. Infect. Dis. 1998, 32:69-73.
348. Perkins E.S., Smith C.H., Schofield P.B. Treatment of uveitis with pyrimethamine (Daraprim). Br. J. Ophthalmol. 1956, 40:577-586.
349. Petersen E., Dubey J.P. Biology of Toxoplasmosis. Clinical Toxoplasmosis: Prevention and Management 2001, 1-42. Cambridge University Press, Cambridge. D.H.M. Joynson, T.G. Wreghitt (Eds.).
350. â automated diagnostic system for determination of specific IgG, IgM and IgG-avidity index in toxoplasmosis. J. Clin. Microbiol. 2005, 43:1570-1574.
351. Petersen E., Kijlstra A., Stanford M. Epidemiology of ocular toxoplasmosis. Ocul Immunol Inflamm 2012 Apr, 20(2):68-75. 10.3109/09273948.2012.661115.
352. Petithory J.C., Reiter-Owona I., Berthelot F., Milgram M., De Loye J., Petersen E. Performance of European Laboratories testing serum samples for Toxoplasma gondii. Eur. J. Clin. Microbiol. Infect. Dis. 1996, 15:45-49.
353. Peyron F., Ateba A.B., Wallon M., et al. Congenital toxoplasmosis in twins: a report of fourteen consecutive cases and a comparison with published data. Pediatr. Infect. Dis. J. 2003, 22:695-701.
354. Peyron F., Garweg J.G., Wallon M., et al. Long-term Impact of Treated Congenital Toxoplasmosis on Quality of Life and Visual Performance. Pediatr. Infect. Dis. J. 2011, 30(7):597-600.
355. Phan L., Kasza K., Jalbrzikowski J., et al. Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Ophthalmology 2008, 115.
356. Phan L., Kasza K., Jalbrzikowski J., et al. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am. J. Ophthalmol. 2008, 146.
357. Pietkiewicz H., Hiszczyńska-Sawicka E., Kur J., Petersen E., Nielsen H.V., Stankiewicz M., Andrzejewska I., Myjak P. Usefulness of T. gondii recombinant antigens in serodiagnosis of human toxoplasmosis. J. Clin. Microbiol. 2004, 42:1779-1781.
358. Pinkerton H., Weinman D. Toxoplasma infection in man. Arch. Pathol. 1940, 30:374-392.
359. Pinon J.M., Chemla C., Villena I., Foudrinier F., Aubert D., Puygauthier-Toubas D., Leroux B., Dupouy D., Quereux C., Talmud M., Trenque T., Potron G., Pluot M., Remy G., Bonhomme A. Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-T. gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J. Clin. Microbiol. 1996, 34:579-583.
360. Pinon J.M., Dumon H., Chemla C., Franck J., Petersen E., Lebech M., Zufferey J., Bessieres M.H., Marty P., Holliman R., Johnson J., Luyasu V., Lecolier B., Guy E., Joynson D.H., Decoster A., Enders G., Pelloux H., Candolfi E. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J. Clin. Microbiol. 2001, 39:2267-2271.
361. Pinto B., Castagna B., Mattei R., Bruzzi R., Chiumiento L., Cristofani R., Buffolano W., Bruschi F. Seroprevalence for toxoplasmosis in individuals living in north west Tuscany: access to Toxo-test in central Italy 2012, 31(6):1151-1156.
362. Pollock J.L. Toxoplasmosis appearing to be dermatomyositis. Arch. Dermatol. 1979, 115:736-737.
363. Post M.J., Chan J.C., Hensley G.T., et al. Toxoplasma encephalitis in Haitian adults with acquired immunodeficiency syndrome: a clinical-pathologic-CT correlation. AJR Am. J. Roentgenol. 1983, 140:861-868.
364. Pouletty P., Kadouche J., Garcia-Gonzalez M., Mihaesco E., Desmonts G., Thulliez P., Thoannes H., Pinon J.M. An anti-human chain monoclonal antibody: use for detection of IgM antibodies to T. gondii by reverse immunosorbent assay. J. Immunol. Meth. 1985, 76:289-298.
365. Prado S.P., Pacheco V.C., Noemi I.H., et al. [Toxoplasma pericarditis and myocarditis]. Rev. Chil. Pediatr. 1978, 49:179-185.
366. Press C., Montoya J.G., Remington J.S. Use of a single serum sample for diagnosis of acute toxoplasmosis in pregnant women and other adults. J. Clin. Microbiol. 2005, 43:3481-3483.
367. Prince H.E., Wilson M. Simplified assay for measuring T. gondii immunoglobulin G avidity. Clin. Diag. Lab. Immunol. 2001, 8:904-908.
368. Prusa A.R., Hayde M., Pollak A., Herkner K.R., Kasper D.C. Evaluation of the liaison automated testing system for diagnosis of congenital toxoplasmosis. Clin. Vaccine Immunol. 2012, 19(11):1859-1863.
369. Rabaud C., May T., Lucet J.C., Leport C., Ambroise-Thomas P., Canton P. Pulmonary toxoplasmosis in patients infected with human immunodeficiency virus: a French National Survey. Clin. Infect. Dis. 1996, 23:1249-1254.
370. Raymond J., Poissonnier M.H., Thulliez P.H., et al. Presence of gamma interferon in human acute and congenital toxoplasmosis. J. Clin. Microbiol. 1990, 28(6):1434-1437.
371. Reischl U., Bretagne S., Krüger D., Ernault P., Costa J.M. Comparison of two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes. BMC Infect. Dis. 2003, 3:7.
372. Reiter-Owona I., Petersen E., Joynson D., Aspöck H., Dardé M.L., Disko R., Dreazen O., Dumon H., Grillo R., Gross U., Hayde M., Holliman R., Ho-Yen D.O., Janitschke K., Jenum P., Naser K., Olszewski M., Thulliez P., Seitz H.M. Looking back on half a century of the Sabin-Feldman dye-test: its past and present role in the serodiagnosis of toxoplasmosis. Results of an European multicentre study 1999, 77. W.H.O., Bull 929-935.
373. Remington J.S., Barnett C.G., Meikel M., et al. Toxoplasmosis and infectious mononucleosis. Arch. Intern. Med. 1962, 110:744-753.
374. Remington J.S., Miller M.J. 19S and 7S anti-toxoplasma antibodies in diagnosis of acute congenital and acquired toxoplasmosis. Proc. Soc. Exp. Biol. Med. 1966, 121:357-363.
375. Remington J.S., Miller M.J., Brownlee I. IgM antibodies in acute toxoplasmosis. I. Diagnostic significance in congenital cases and a method for their rapid demonstration. Pediatr. 1968, 41:1082-1091.
376. Remington J.S. Toxoplasmosis in the adult. Bull. N. Y. Acad. Med. 1974, 50:211-227.
377. Remington J.S., Desmonts G. Congenital Toxoplasmosis. Infectious diseases of the foetus and newborn infant 1976, 297-299. WB Saunders, Philadelphia, PA. first ed. J.S. Remington, J.O. Klein (Eds.).
378. Remington J.S., Araujo F.G., Desmonts G. Recognition of different Toxoplasma gondii antigens by IgM and IgG antibodies in mothers and their congenitally infected newborns. J. Infect. Dis. 1985, 152:1020-1024.
379. Remington J.B., Wilder Antunes F., et al. Clindamycin for toxoplasmosis encephalitis in AIDS (letter). Lancet 1991, 338:1142-1143.
380. Remington J.S., McLeod R., Thulliez P. Toxoplasmosis. Infectious Diseases of the Foetus and Newborn Infant 2001, 205-346. WB Saunders, Philadelphia. J.S. Remington, J. Klein (Eds.).
381. Remington J.S., Thulliez P., Montoya J.G. Recent developments for diagnosis of toxoplasmosis. J. Clin. Microbiol. 2004, 42(3):941-945.
382. Remington J.S., McLeod R., Thulliez P., Desmonts G. Toxoplasmosis. Infectious Diseases of the Foetus and Newborn Infant 2011, WB Saunders, Philadelphia, PA. seventh ed. J. Remington, J. Klein (Eds.).
383. Renier D., Sainte-Rose C., Pierre-Kahn A., Hirsch J.F. Prenatal hydrocephalus: outcome and prognosis. Childs Nerv. Syst. 1988, 4(4):213-222.
384. Renoult E., Georges E., Biava M.F., Hulin L., Frimat D., Hestin D., Kessler M. Toxoplasmosis in kidney transplant recipients: report of six cases and review. Clin. Infect. Dis. 1997, 24:625-634.
385. Rigsby P., Rijpkema S., Guy E.C., Francis J., Das R.G. Evaluation of a candidate international standard preparation for human anti-Toxoplasma immunoglobulin G. J. Clin. Microbiol. 2004, 42:5133-5138.
386. Rilling V., Dietz K., Krczal D., Knotek F., Enders G. Evaluation of a commercial IgG/IgM Western blot assay for early postnatal diagnosis of congenital toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 2003, 22:174-180.
387. Robert A., Luyasu V., Zuffrey J., Hedman K., Petersen E., European Network on Congenital Toxoplasmosis Potential of the specific markers in the early diagnosis of Toxoplasma-infection: A multicentre study using combination of isotype IgG, IgM, IgA and IgE with values of avidity assay. Eur. J. Clin. Microbiol. Infect. Dis. 2001, 20:467-474.
388. Robert-Gangneux F., Commerce V., Tourte-Schaefer C., Dupouy-Camet J. Performance of a Western blot assay to compare mother and newborn anti-Toxoplasma antibodies for the early neonatal diagnosis of congenital toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 1999, 18:648-654.
389. Roizen N., Swisher C.N., Stein M.A., et al. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 1995, 95:11-20.
390. Roizen N., Kasza K., Karrison T., et al. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies. Pediatrics 2006, 118:e379-e390.
391. Rollins-Raval M.A., Marafioti T., Swerdlow S.H., Roth C.G. The number and growth pattern of plasmacytoid dendritic cells vary in different types of reactive lymph nodes: an immunohistochemical study. Hum. Pathol 2012.
392. Romand S., Pudney M., Derouin F. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. Antimicrob. Agents Chemother. 1993, 37(11):2371-2378.
393. Romand S., Chosson M., Franck J., et al. Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of foetal infection with Toxoplasma gondii. Am. J. Obstet. Gynecol. 2004, 190:797-802.
394. Rossi C.L. A simple, rapid enzyme-linked immunosorbent assay for evaluating immunoglobulin G antibody avidity in Toxoplasmosis. Diag. Microbiol. Infect. Dis. 1998, 30:25-30.
395. Roue R., Debord T., Denamur E., Ferry M., Dormont D., Barre-Sinoussi F., Rouzioux C. Diagnosis of Toxoplasma encephalitis in absence of neeurological signs by early computerised tomography scanning in patients with AIDS. Lancet ii. 1984, 1472.
396. Roux C., Desmont G., Mulliez N., et al. [Toxoplasmosis and pregnancy. Evaluation of 2 years of prevention of congenital toxoplasmosis in the maternity ward of Hôpital Saint-Antoine (1973-1974)]. J. Gynecol. Obstet. Biol. Reprod. (Paris) 1976, 5(2):249-264.
397. Ruskin J., Remington J.S. Toxoplasmosis in the compromised host. Ann. Intern. Med. 1976, 84:193-199.
398. Ryning F.W., McLeod R., Maddox J.C., et al. Probable transmission of Toxoplasma gondii by organ transplantation. Ann. Intern. Med. 1979, 90:47-49.
399. Saadatnia G., Mohamed Z., Ghaffarifar F., Osman E., Moghadam Z.K., Noordin R. Toxoplasma gondii excretory secretory antigenic proteins of diagnostic potential. APMIS 2012, 120(1):47-55.
400. Sabin A.B. Toxoplasmic encephalitis in children. J. Am. Med. Assoc. 1941, 116:801-807.
401. Sabin A.B., Feldman H.A. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoan parasite (Toxoplasma). Science 1948, 108:660-663.
402. Samuel B.U., Hearn B., Mack D., Wender P., Rothbard J., Kirisits M.J., Mui E., Wernimont S., Roberts C.W., Muench S.P., Rice D.W., Prigge S.T., Law A.B., McLeod R. Delivery of antimicrobials into parasites. Proc. Natl. Acd. Sci. USA 2003, 100(24):14281-14286.
403. dos Santos T.R., Nunes C.M., Luvizotto M.C., et al. Detection of Toxoplasma gondii oocysts in environmental samples from public schools. Vet. Parasitol. 2010, 171(1-2):53-57.
404. Saxon S.A., Knight W., Reynolds D.W., Stagno S., Alford C.A. Intellectual deficits in children born with subclinical congenital toxoplasmosis: a preliminary report. J. Pediatr. 1973, 85(5):792-797.
405. Schaefer L.E., Dyke J.W., Meglio F.D., Murray P.R., Crafts W., Niles A.C. Evaluation of microparticle enzyme immunoassays for immunoglobulins G and M to rubella virus and Toxoplasma gondii on the Abbott IMx automated analyzer. J. Clin. Microbiol. 1989, 27:2410-2413.
406. Schreiner M., Liesenfeld O. Small intestinal inflammation following oral infection with Toxoplasma gondii does not occur exclusively in C57BL/6 mice: review of 70 reports from the litreature. Mem. Inst. Oswaldo Cruz 2009, 104(2):221-233.
407. Sensini A., Pascoli S., Marchetti D., Castronari A., Marangi M., Sbaraglia G., Cimmino C., Favero A., Castelletto M., Mottola A. IgG avidity in the serodiagnosis of acute T. gondii infection: a multicentre study. Clin. Microbiol. Infect. 1996, 2:25-29.
408. Severance E.G., Kannan G., Gressitt K.L., Xiao J., Alaedini A., Pletnikov M.V., Yolken R.H. Anti-gluten immune response following Toxoplasma gondii infection in mice 2012, 7(11). E50991.
409. Shapiro K., Conrad P.A., Mazet J.A., et al. Effect of estuarine wetland degradation on transport of Toxoplasma gondii surrogates from land to sea. Appl. Environ. Microbiol. 2010, 76(20):6821-6828.
410. Sibley L.D., Boothroyd J.C. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 1992, 359:82-85.
411. Siegel S.E., Lunde M.N., Gelderman A.H., et al. Transmission of toxoplasmosis by leukocyte transfusion. Blood 1971, 37:388-394.
412. Siim J.C. Acquired toxoplasmosis: report of seven cases with strongly positive serologic reactions. J. Am. Med. Assoc. 1951, 147:1641-1645.
413. Silveira C., Belfort R., Burnier M., et al. Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am. J. Ophthalmol. 1988, 106:362-364.
414. Silveira C., Belfort R., Muccioli C., Abreu M.T., Martins M.C., Victora C., Nussenblatt R.B., Holland G.N. A follow-up study of Toxoplasma gondii infection in southern Brazil. Am. J. Ophthalmol. 2001, 131:351-354.
415. Silveira C., Belfort R., Muccioli C., Holland G.N., Victora C.G., Horta B.L., Yu F., Nussenblatt R.B. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am. J. Ophthalmol. 2002, 134(1):41-46.
416. Sing A., Leitritz L., Roggenkamp A., et al. Pulmonary toxoplasmosis in bone marrow transplant recipients: report of two cases and review. Clin. Infect. Dis. 1999, 29:429-433.
417. Singer M.A., Hagler W.S., Grossniklaus H.E. Toxoplasma gondii retinochoroiditis after liver transplantation. Retina 1993, 13:40-45.
418. Singh U., Brewer J.L., Boothroyd J.C. Genetic analysis of tachyzoite to bradyzoite differentiation mutants in T. gondii reveals a hierarchy of gene induction. Mol. Microbiol. 2002, 44:721-733.
419. Slavin M.A., Meyers J.D., Remington J.S., et al. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 1994, 13:549-557.
420. Sørensen T., Spenter J., Jaliashvili I., Christiansen M., Nørgarrd-Pedersen B., Petersen E. An automated time-resolved immunofluometric assay for detection of T. gondii -specific IgM and IgA antibodies in filterpaper samples from newborns. Clin. Chemistry 2002, 48:1981-1986.
421. Stagno S., Reynolds D.W., Amos C.S., et al. Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegaloviral and Toxoplasma infections. Pediatrics 1977, 669-678.
422. Steen E., Kåss E. A new Toxoplasma antigen for complement fixation test. Acta Path. Microbiol. Scand. 1951, 28:36-39.
423. Stepick-Biek P., Thulliez P., Araujo F.G., Remington J.S. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J. Infect. Dis. 1990, 162(1):270-273.
424. Stillwaggon E., Carrier C.S., Sautter M., McLeod R. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl. Trop. Dis. 2011, 5(9):e1333.
425. Stommel E.W., Seguin R., Thadani V.M., Schwartzman J.D., Gilbert K., Ryan K.A., Tosteson T.D., Kasper L.H. Cryptogenic epilepsy: an infectious etiology?. Epilepsia 2001, 42(3):436-438.
426. Strabelli T.M., Siciliano R.F., Vidal Campos S., Bianchi Castelli J., Bacal F., Bocchi E.A., Uip D.E. Toxoplasma gondii Myocarditis after Adult Heart Transplantation: Successful Prophylaxis with Pyrimethamine. J. Trop. Med. 2012, 2012:853562.
427. Suzuki Y., Israelski D.M., Dannemann B.R., Stepick-Biek P., Thulliez P., Remington J.S. Diagnosis of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome by using a new serological method. J. Clin. Microbiol. 1988, 26:2541-2543.
428. Suzuki Y., Thulliez P., Desmonts G., Remington J.S. Antigen(s) responsible for immunoglobulin G responses specific for the acute stage of Toxoplasma infection in humans. J. Clin. Microbiol. 1988, 26(5):901-905.
429. Swisher C.N., Boyer K., McLeod R., The Toxoplasmosis Study Group Congenital toxoplasmosis. Semin. Pediatr. Neurol. 1994, 4-25.
430. Switaj K., Master A., Skrzypczak M., Zaborowski P. Recent trends in molecular diagnostics for Toxoplasma gondii infections. Clin. Microbiol. Infect. 2005 Mar, 11(3):170-176.
431. SYROCOT - Systemic Review on Congenital Toxoplasmosis Study Group, Thiebaut R., Leproust S., Chene G., Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 2007, 369:115-122.
432. Tabbara K.F., O'Connor G.R. Treatment of ocular toxoplasmosis with clindamycin and sulfadiazine. Opthalmology 1980, 87:129-134.
433. Tan T.G., Mui E., Cong H., et al. Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans. Vaccine 2010, 28(23):3977-3989.
434. Teutsch S.M., Juranek D.D., Sulzer A., Dubey J.P., Sikes R.K. Epidemic toxoplasmosis associated with infected cats. N. Engl. J. Med. 1979, 300:695-699.
435. Thalhammer O. Die Toxoplasmose-Untersuchung von Schwangeren und neugeborenen. Wien Klein. Wochenschr. 1975, 87:676-681.
436. Thalib L., Gras L., Romand S., Prusa A., Bessieres M.H., Petersen E., Gilbert R.E. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG 2005 May, 112(5):567-574.
437. Thulliez P., Remington J.S., Santoro F., et al. A new agglutination test for the diagnosis of acute and chronic Toxoplasma infection. Pathol. Biol. (Paris) 1986, 34:173-177.
438. Thulliez P., Remington J.S., Santoro F., Ovlaque G., Sharma S., Desmonts G. A new agglutination reaction for the diagnosis of the development stage of acquired toxoplasmosis. Pathol. Biol. Paris 1989, 34:173-177.
439. Thulliez P. Screening programme for congenital toxoplasmosis in France. Scand. J. Infect. Dis. 1992, 84(Suppl.):43-45.
440. Thulliez P. Commentary: Efficacy of prenatal treatment for toxoplasmosis: a possibility that cannot be ruled out. Int. J. Epidemiol. 2001, 30:1315-1316.
441. Thulliez P. Maternal and foetal infection. Toxoplasmosis: A comprehensive clinical guide 2001, 193-213. Cambridge University Press. D.H.M. Joynson, T.G. Wreghitt (Eds.).
442. Tissot-Dupont D., Fricker-Hidalgo H., Brenier-Pinchart M.P., Bost-Bru C., Ambroise-Thomas P., Pelloux H. Usefulness of Western blot in serological follow-up of newborns suspected of congenital toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 2003, 22:122-125.
443. de-la-Torre A., González G., Díaz-Ramirez J., Gómez-Marín J.E. Screening by ophthalmoscopy for Toxoplasma retinochoroiditis in Colombia. Am. J. Ophthalmol. 2007, 143:354-356.
444. Toporovski J., Romano S., Hartmann S., Benini W., Chieffi P.P. Nephrotic syndrome associated with toxoplasmosis: report of seven cases. Rev. Inst. Med. Trop. Sao Paulo 2012, 54(2):61-64.
445. Torres R., Barr M., Thorn M., Gregory G., Kiely S., Chanin E., Carlo C., Martin M., Thornton J. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. American Journal of Medicine 1993, 95:573-583.
446. Torrey E.F., Bartko J.J., Yolken R.H. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr. Bull. 2012, 38(3):642-647.
447. Townsend J.J., Wolinsky J.S., Baringer J.R., Johnson P.C. Acquired toxoplasmosis. A neglected cause of treatable nervous system disease 1975, 32(5):335-343.
448. Vallochi A.L., Muccioli C., Martins M.C., Silveira C., Belfort R., Rizzo L.V. The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil. Am. J. Ophthalmol. 2005, 139:350-351.
449. Vasconcelos-Santos D.V., Machado Azevedo D.O., Campos W.R., Oréfice F., Queiroz-Andrade G.M., et al. Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology 2009, 116:2199-2205.
450. Vasconcelos-Santos D.V., Queiroz Andrade G.M. Geographic differences in outcomes of congenital toxoplasmosis. Pediatr. Infect. Dis. J. 2011, 30(9):816-817.
451. Vasconcelos-Santos D.V. Ocular manifestations of systemic disease: toxoplasmosis. Curr. Opin. Ophthalmol. 2012, 23(6):543-550.
452. Vaudaux J.D., Muccioli C., James E.R., et al. Identification of an Atypical Strain of Toxoplasma gondii as the Cause of a Waterborne Outbreak of Toxoplasmosis in Santa Isabel do Ivai. Brazil J. Infect. Dis. 2010, 202:1226-1233.
453. Vaughan L.B., Wenzel R.P. Disseminated toxoplasmosis presenting as septic shock five weeks after renal transplantation. Transpl. Infect. Dis 2012.
454. Vidal J.E., Colombo F.A., de Oliveira A.C., Focaccia R., Pereira-Chioccola V.L. PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients. J. Clin. Microbiol. 2004, 42:4765-4768.
455. Vietzke W.M., Geldermann A.H., Grimley P.M., et al. Toxoplasmosis complicating malignancy: experience at the National Cancer Institute. Cancer 1968, 21:816-827.
456. Villard O., Breit L., Cimon B., Franck J., Fricker-Hidalgo H., Godineau N., Houze S., Paris L., Pelloux H., Villena I., Candolfi E., the French National Reference Centre for Toxoplasmosis Network Comparison of four commercially available avidity tests for Toxoplasma-specific IgG antibodies. Clin. Vaccine Immunol 2012.
457. Villena I., Ancelle T., Delmas C., et al. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro. Surveill. 2010, 15. pii-19600.
458. Vogel N., Kirisits M., Michael E., Bach H., Hostetter M., Boyer K., Simpson R., Holfels E., Hopkins J., Mack D., Mets M.B., Swisher C.N., Patel D., Roizen N., Stein L., Stein M., Withers S., Mui E., Egwuagu C., Remington J., Dorfman R., McLeod R. Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception. Clinical Infectious Diseases 1996, 23:1055-1060.
459. Villavedra M., Battistoni J., Nieto A. IgG recognizing 21-24 kDa and 30-33 kDa tachyzoite antigens show maximum avidity maturation during natural and accidental human toxoplasmosis. Rev. Inst. Med. Trop. Sao Paulo 1999, 41:297-303.
460. Vyas A., Sapolsky R. Manipulation of host behaviour by Toxoplasma gondii: what is the minimum a proposed proximate mechanism should explain?. Folia Parasitol. (Praha) 2010, 57(2):88-94.
461. Wainwright K.E., Miller M.A., Kreuder C., et al. Chemical inactivation of Toxoplasma gondii oocysts in water. J. Parasitol. 2007, 93:925-931.
462. Wallon M., Cozon G., Ecochard R., Lewin P., Peyron F. Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children. Eur. J. Pediatr. 2001, 160:534-540.
463. Wallon M., Kodjikian L., Binquet C., et al. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatr. 2004, 113:1567-1572.
464. Wallon M., Franck J., Thulliez P., et al. Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid. Obstet. Gynecol. 2010, 115:727-733.
465. Wallon M., Kieffer F., Binquet C., Thulliez P., Garcia-Meric P., Dureau P., Franck J., Peyron F., Bonnin A., Villena I., Bonithon-Kopp C., Gouyon J.B., Masson S., Felin A., Cornu C. Congenital toxoplasmosis: randomized comparison of strategies for retinochoroiditis prevention. Therapie 2011, 66(6):473-480.
466. Wallon M., Peyron F., Cornu C., Vinault S., Abrahamowicz M., Bonithon Kopp C., Binquet C. Congenital Toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at 3 years. Clin. Infect. Dis. 2013, Epub ahead of print.
467. Walls K.W., Bullock S.L., English D.K. Use of the enzyme-linked immunosorbent assay (ELISA) and its microadaptation for the serodiagnosis of toxoplasmosis. J. Clin. Microbiol. 1977, 5:273-277.
468. Warren J., Sabin A.B. The complement fixation reaction in Toxoplasma infection. Proc. Soc. Exp. Biol. Med. 1942, 51:11-14.
469. Webster J.P., Lamberton P.H., Donnelly C.A., Torrey E.F. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc. Biol. Sci. 2006, 273(1589):1023-1030.
470. Webster J.P., Kaushik M., Bristow G.C., McConkey G.A. Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?. J. Exp. Biol. 2013, 216(Pt 1):99-112.
471. Weiss L.M., Harris C., Berger M., Tanowitz H.B., Wittner M. Pyrimethamine concentration in serum and cerebrospinal fluid during treatment of Toxoplasma encephalitis in patients with AIDS. Journal of Infectious Diseases 1988, 157:580-583.
472. Weiss L.M., Dubey J.P. Toxoplasmosis: A history of clinical observations. Int. J. Parasitol. 2009, 39(8):895-901.
473. Wilson C., Remington J.S., Stagno S., Reynolds D.W. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980, 66:767-774.
474. Wilson C.B., Desmonts G., Couvreur J., Remington J.S. Lymphocyte transformation in the diagnosis of congenital toxoplasma infection. N. Engl. J. Med. 1980, 302(14):785-788.
475. Witola W.H., Mui E., Hargrave A., et al. NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells. Infect. Immun. 2011, 79(2):756-766.
476. Wolf A., Cowen D., Paige B.H. Toxoplasmic encephalomyelitis III. A new case of ganulomatous encephalitis due to a protozoon. Am. J. Pathol. 1939, 15:657-694.
477. Wong W.K., Upton A., Thomas M.G. Neuropsychiatric symptoms are common in immunocompetent adult patients with Toxoplasma gondii acute lymphadenitis. Scand. J. Infect. Dis 2012.
478. Wong S.Y., Hajdu M.P., Ramirez R., et al. Role of specific immunoglobulin E in diagnosis of acute Toxoplasma infection and toxoplasmosis. J. Clin. Microbiol. 1993, 31(11):2952-2959.
479. Wreghitt T.G., Gray J.J., Pavel P., Balfour A., Fabbri A., Sharples L.D., Wallwork J. Efficacy of pyrimethamine for the prevention of donor-acquired T. gondii infection in heart and heart-lung transplant patients. Transplant Int. 1992, 5:197-200.
480. Wreghitt T.G., McNeil K., Roth C., et al. Antibiotic prophylaxis for the prevention of donor-acquired Toxoplasma gondii infection in transplant patients. [letter, comment]. J. Infect. 1995, 31:253-254.
481. Wulf M.W.H., van Crevel R., Portier R., Meulen C.G., Melchers W.J.G., van der Ven, A., Galama J.M.D. Toxoplasmosis after renal transplantation: Implications of a missed diagnosis. J. Clin. Microbiol. 2005, 43:3544-3547.
482. Xiao J., Kannan G., Jones-Brando L., Brannock C., Krasnova I.N., Cadet J.L., Pletnikov M., Yolken R.H. Sex-specific changes in gene expression and behaviour induced by chronic Toxoplasma infection in mice. Neuroscience 2012, 206:39-48.
483. Xiao J., Viscidi R.P., Kannan G., Pletnikov M.V., Li Y., Severance E.G., Yolken R.H., Delhaes L. The Toxoplasma MAG1 peptides induce sex-based humoral immune response in mice and distinguish active from chronic human infection. Microbes. Infect 2012.